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Chapter 1 
Introduction 
 
1.1. Medical devices and biocompatible materials 
   Over several decades, the rapid development of science and technology has been 
keeping clinical practice advanced and contributing a great deal of medical care for 
innumerable people [1.1-3]. The development of material science and material 
engineering also results in making use of powerful clinical application [1.4]. Although 
various kinds of artificial material such as metal, ceramic and polymer have found clinical 
application, host response and foreign body reaction to biomaterial remain matters of 
especially serious concern [1.5]. Our bodies detect not only an infection by viruses and 
bacteria but also an invasion by foreign material. When our living bodies contact with 
foreign substances, the reaction such as inflammatory responses occurs, regardless of 
their biocompatibility [1.6, 7]. Surface characteristics are significant material variables 
that influence the host response [1.5]. Therefore, surface modification is received 
growing interests in biomedical engineering as an effective method for improvement of 
biomaterial [1.8-10]. The surface coating is one method of surface modification, and 
various coating materials have been developed for medical devices as well as industrial 
products such as engine components and cutting tools. In this thesis, I evaluate blood-
compatible surface coating materials and propose new technologies to apply them to 
blood-contacting medical devices.   
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1.2. Development of blood-contacting implantable devices 
Since the late 1900s, many kinds of implants that regularly contact with human blood 
have been developed to treat our bodies. In 1950s, development of artificial grafts was 
progressed and vascular replacement by grafts has been widespread in surgical field to 
treat arterial disease [1.11, 12]. The first implantation of artificial valves in a patient was 
also performed around the same time [1.13]. In 1960s, M.E. DeBakey et al. reported the 
first implantation of left ventricular assist devise (LVAD), which is one kind of artificial 
hearts [1.14]. From 1990s, stent placement into the stenotic artery has contributed 
considerable improvement for a number of patients. After development of endovascular 
stents which are developed to prevent occlusion and restenosis after percutaneous 
transluminal angioplasty, various kinds of stents have been widely used for various 
treatments of diseases as minimally invasive therapy. Stenting for coronary artery and 
superficial femoral artery diseases, and stent-graft repair of aortic aneurysm had 
developed in late 1980s and they have become more and more popular than surgery in 
medical site [1.15, 16]. From early 2000s, stent valves had developed for transcatheter 
aortic-valve implantation and have contributed to treatments of valve dysfunction and 
aortic stenosis as a less invasive treatment for high-risk patients who cannot undergo 
surgery for replacement of the artificial valve [1.17, 18]. For the treatment of 
cerebrovascular diseases, furthermore, retrievable stents and flow diverter stents offer the 
potential of recanalization by clot removal and aneurysm occlusion related to flow 
disruption, respectively [1.19, 20]. In this way, developing various types of stents have 
replaced invasive surgeries with minimally invasive operations for the treatment of 
vascular diseases.  
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1.3. Biological response of blood components on artificial surfaces 
   The biological response to implanted devices is regulated largely by cell-material 
interactions. Especially for the vascular implants, the device surface comes in contact 
with blood and cells that make up blood vessels. After the implantation, the biological 
matters and molecules, such as blood cells, plasma proteins and blood vessel tissues, 
immediately contact to the implant surface, and then various biological matters produce 
several reactions against the artificial surface. The biological reaction is mainly 
comprised of four parts, that is, protein adsorption, complements activation, blood cells 
adhesion and blood vessel tissue response (Figure 1.1).  
   When medical devices directly have contact with blood after introduction to the 
bodies, a cross-reaction between artificial surface and blood components arises. These 
reactions trigger thrombus formation and chronic inflammation of implanted sites. 
Thrombosis caused by placement of artificial materials or devices is called material-
associated or device-induced thrombosis [1.21, 22]. The most rapid reaction is the 
adsorption of plasma proteins, and this occurs in the few seconds after contact [1.23]. 
Surface composition of adsorbed proteins changes with time and it is affected with surface 
chemical characteristics [1.24]. Blood contains various kinds of proteins, which 
contribute to coagulation, fiblinolysis and inflammation systems. Adsorbed plasma 
proteins control successive complement activation, blood cells adhesion and blood vessel 
tissue response. Among several proteins, fibrinogen, fibronectine, vitronectine and von 
Willibrand Factors are known as key factors that deeply contribute to thrombus formation 
on the surface, because these proteins specifically bind the platelet membrane protein, 
GPIIb/IIIa. In particular, it is suggested that fibrinogen is the most important to platelet 
adhesion to artificial surface [1.25].  
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Figure 1.1. Overview of biological interaction between biomaterial surface and 
biological organs. 
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   Platelets are anucleate blood particles that play a crucial role in hemostasis and in 
wound healing by adhesion. Platelets act the main factor of clot formation. An adsorbed 
fibrinogen layer on the surface also contributes to the complement activation [1.26] and 
leukocytes reactions: adhesion; activation and migration [1.27, 28]. Both the complement 
activation and leukocytes reaction induce inflammation around the implanted sites. In 
early phase after implantation, the biological reaction on the surface occurs by cascade 
reaction involving plasma proteins and blood cells, predominantly. Additionally, the 
release of biological matters that promotes cell growth and proliferation from blood cells 
affects latter reaction of vascular wall tissues [1.29].  
Although endovascular stent implantation is widely accepted as the minimally 
invasive treatment for more than 20 years, there remain serious concerns that human body 
reactions lead to complication or device failure in some cases [1.30]. Therefore, the 
development of antithrombogenic material for blood-contacting devices has been one of 
the great interests in the field of material science and engineering. 
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Figure 1.2. SEM image of platelet adhesion, activation and migration on the 
biomaterial. 
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1.4. Hydrogenated amorphous carbon (a-C:H) films for biocompatible coating 
   While progressive development of materials or design has resulted in suppression of 
complications in medical devices, there still does not exist ideal materials for implantable 
medical devices which can help patients recover completely without risks of complication 
caused by host responses [1.31]. Therefore, many researchers have investigated various 
materials with good biocompatibility and blood-compatibility to improve medical 
treatments. From the point of chemical inertness and barrier properties to metal ion 
release, the carbon coating had regarded as a great candidate for antithrombogenic surface 
in blood-contacting materials [1.32]. In this research, I especially focused on the 
hydrogenated amorphous carbon (a-C:H) coatings as biocompatible carbon thin films. 
Here, I overview the a-C:H films and its potential as biocompatible coatings. 
Amorphous-C:H consisting of mixture of sp3 and sp2 was first introduced by Aisenber 
and Chabot [1.33]. The a-C:H film, which is sometimes known as diamond-like carbon 
(DLC), have received much attention in various fields owing to their excellent and unique 
properties such as high hardness, low frictional coefficient, high wear and corrosion 
resistance, chemical inertness, excellent smoothness and biocompatibility [1.34]. All 
excellent properties of DLC match well with the criteria of a good biomaterial for 
applications. Moreover, DLC has attracted much attention in biomaterial science, since 
DLC coating has reported to exhibit good hemocompatibility [1.35]. Because of its 
amorphous structure, furthermore, DLC films can be easily doped and alloyed with 
different element and this leads to a wide range of properties depending on its sp3, sp2, 
and hydrogen content together with element incorporation. This results in developing 
various kinds of antithrombogenic element-doped DLC for implantable medical devices 
in the world.  
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1.5. Development of antithrombogenic a-C:H coating by element-doping  
   The properties of a-C:H (DLC) films critically depend on the deposition condition, 
and therefore published scientific results from different research groups can sometimes 
not be directly compared. However, there have been several reports that show the 
reduction of platelet adhesion on DLC films. It is reported that the sp3 and sp2 carbon, 
hydrogen, dopant element influence hemocompatibility of DLC, as they determined other 
properties of DLC films.  
   It is reported that sp3 and sp2 carbon affect blood compatibility of DLC. Chen et al. 
and Leng et al. investigated the relationship between the sp3 and sp2 ratio in DLC films 
and platelet adhesion on them by controlling the sp3 and sp2 ratio [1.36, 37]. Their results 
implied that sp3 and sp2 ratio influences blood compatibility of DLC and DLC with proper 
sp3 and sp2 ratio suppresses platelet adhesion. Hydrogen in DLC also influences blood 
compatible properties. Yamato et al. reported that hydrogen-free DLC which contains no 
hydrogen in the film reduces the number of adhesive platelets and suppresses platelet 
activation in comparison with hydrogenated DLC [1.38].  
   Concerning element doping, various research groups study about relationship 
between dopant element into DLC film and hemocompatibility. Kwok et al. fabricated 
phosphorous-doped DLC (P-DLC) which suppressed the adhesion and activation of 
platelets compared with non-doped DLC and biocompatible low temperature isotopic 
carbon (LITC) and concluded the hemocompatibility of P-DLC is relative with its 
interfacial tension with plasma protein [1.39]. On the other hands, they also showed only 
optimal amount of phosphorus is important to exhibit less platelet adhesive and activation 
[1.40]. Furthermore, they reported that calcium doped DLC similarly shows as good 
hemocompatibility as P-DLC, although doping both Ca and P into DLC (CaP-DLC) 
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results in fabrication of inferior blood-compatible coating compared with Ca-DLC and P-
DLC [1.41]. In addition, they also improved hemocompatibility of hydrogen-free DLC 
film by the addition of nitrogen into the film. The number of adherent platelets and 
percentage of activated platelets are small on hydrogen-free DLC with proper nitrogen 
concentration [1.42]. Okpalugo et al. investigated hemocompatibility of Si doped DLC 
(Si-DLC) and concluded that Si-DLC leads to lower levels of platelet aggregation 
compared with non-treated DLC [1.43]. Roy et al. enhanced hemocompatibility of Si-
DLC films by N2- and O2-plasma-treatment to the surface of them [1.44]. According to 
the report written by Nagashima et al., O2-plasma-treatment also improves the 
antithrombogenicity of non-doped DLC. In addition to these results, there are many 
reports that platelet adhesion is suppressed by doping metal element such as Ag, Ti or W. 
These results show that DLC, especially element alloyed DLC, suppresses platelet 
adhesion on their surface, although the blood coagulation mechanism on DLC films in 
biological environment has not been well understood so far. 
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1.6. Development of blood-compatible fluorinated a-C:H coating   
   Since 2005, an engineering analysis of fluorine-doped a-C:H (a-C:H:F or F-DLC) 
films and quantitative and morphological studies on antithrombogenic properties to a-
C:H:F films have been presented. In the previous study [1.45], an addition of fluorine into 
a-C:H films enhanced the water-shedding properties, and improved antithrombogenicity 
of a-C:H films by reducing the number of platelets per unit area (Fig. 1.2). Furthermore, 
it is reported that this results from the highest ratio of albumin/fibrinogen adsorption of 
a-C:H:F film [1.46]. The antithrombogenicity of a-C:H:F films is promoted by the 
existence of the localized fluorine in the top-most thin layer of a-C:H:F film [1.47]. 
Furthermore, the antithrombogenic a-C:H:F films shows lower numbers of adherent 
platelets and less platelet activation than existing antithrombotic biomaterials such as 
polycarbonate and stainless steel 316L [1.46, 48, 49]. In 2010s, Jongwannasiri et al. and 
Chou et al. similarly also reported that a-C:H:F coating suppressed the platelet adhesion 
on Titanium alloys [1.50, 51]. From these results, a-C:H:F film can be a promising 
candidate for blood-compatible coating of implantable devices. The anti-inflammatory 
property of a-C:H:F films were also shown by evaluating the adhesion of neutrophils 
which play roles in inflammatory responses to biomaterials [1.52]. Furthermore, a-C:H:F 
surface does not disturb human umbilical vein endothelial cells (HUVECs) proliferation 
and allows the preservation of endothelialization, and fluorescent immune microscopic 
observation indicated that the focal adhesion protein, vinculin, expressed in HUVECs 
attached to the a-C:H:F surface in a manner similar to that observed with a-C:H surfaces 
[1.53]. In vivo study, it is reported that histocompatibility of a-C:H:F was almost equal to 
that of stainless steel 316L [1.49]. These results indicate that the a-C:H:F coating may be 
useful for blood-contacting medical devices.   
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Figure 1.3. Adherent platelets on (a) polycarbonate (control material), (b) a-C:H 
(DLC), and (c) a-C:H:F (F-DLC).  
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1.7. Thesis Overview 
   In medicine, endovascular stent implantation has been becoming a useful option to 
treat vascular diseases. However, device-induced thrombosis and in-stent restenosis 
remain as complications after stent implantation. To improve such complications, 
development of stent coatings is expected, and amorphous carbon and diamond-like 
carbon which shows good blood-compatibility can be a candidate for stents. Although 
more study and long-term implantation are needed, various kinds of element-doped DLC 
films can reduce the thrombus formation after medical device implantation.  
  The aim of this study summarized in the thesis is to develop well-biocompatible surface 
by applying the amorphous carbon coatings. This thesis is divided into four parts of 
researches. The first part is a study of fluorine-incorporated hydrogenated amorphous 
carbon (a-C:H:F) films. In chapter 2, the stability of a-C:H:F films was evaluated for 
commercialization. As an aging test for a-C:H:F film under various temperature 
conditions, the antithrombogenic and adhesive properties to SUS316L stents were 
evaluated for commercialization. I tried to show the aging of a-C:H:F film using 
accelerated aging tests, mainly focusing on surface chemistry, contact angles of surfaces, 
antithrombogenic properties and adhesive properties. In the second part, a-C:H:F coating 
was applied to conventional medical polymers. In the second part, it is summarized about 
newly evaluated a-C coating surface that has hemocompatibility and mechanical 
properties. In chapter 3, poor adhesive properties of a-C:H:F surface were focused and 
studied for an anti-sticking layer on medical devices. The adhesiveness of the a-C:H:F 
coated polymer to a therapeutic adhesive agent was evaluated. On the other hands, in 
chapter 4, a-C:H:F was used as an interlayer of medical fluoropolymer and the anti-
bacterial amorphous carbon film and improved adhesive properties of them. The blood-
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compatible and antithrombotic properties of hydrogen-free amorphous carbon (H-free a-
C) are presented. The method to improve adhesion property between H-free a-C and 
polytetrafluoroethylene, which is one of the popular medical polymer material, is also 
shown. As the third part, the antithrombotic property and mechanical property of fluorine-
incorporated hydrogen-free amorphous carbon (a-C:F) surfaces was newly developed and 
evaluated in chapter 5. The chemical composition, bonding state, and carbon 
microstructure were analyzed, and anti-thrombogenicity was evaluated with the dipping 
test to plasma protein and platelet rich plasma. The last part of this research focuses on 
the fundamental mechanisms of platelet adhesion and activation on a-C coating materials 
surface. To observe the surface adherent platelet and the characteristic of the movement 
of platelet internal granules and adhesion interface with transmission electron microscopy 
new embedding method is proposed and improved images are shown in chapter 6. 
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Chapter 2 
Time course analysis of antithrombogenic properties of 
fluorinated diamond-like carbon coating  
 
2.1 Introduction 
2.1.1. Problems of stent implantation: thrombosis and restenosis 
   As described in chapter 1, thrombus formation is a serious concern in the stent 
implantation. The blood clots induce not only thrombosis but also re-narrowing of arterial 
wall by smooth muscle cell hyperproliferation/migration, which is called in-stent 
restenosis [2.1, 2]. Although the antithrombogenic properties of stents are indispensable 
for prevention of such complications, it is known that the conventional bare metal stents 
(BMS) can induce early thrombosis within 30 days, followed re-narrowing of artery [2.3]. 
In stent valve implantation, pathological and clinical findings elucidated the occurrence 
of valve thrombosis post-treatment [2.4, 5]. It is also reported that thromboembolic event 
results in death of patients in endovascular treatments using flow-diverter stents [2.6]. 
Therefore, the development of antithrombogenic material for stents has been one of the 
great interests in the field of material science and engineering. 
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2.1.2. Development of stent coating: active and passive coating 
In the development of stents, the stent coating has been developed to improve surface 
characteristics of stents which influence the stent-biology interaction, while development 
of bulk material also has been driven by the need to improve long term outcomes [2.7, 8]. 
To improve stent-biology interaction, two concepts of stent coating, namely, active and 
passive coatings, have been developed in general [2.9, 10].  
The active coating which contains anti-proliferative drugs, such as anti-cancer agents, 
actively suppresses tissue and cell reaction induced by the contact between human bodies 
and biomaterials. Drug-eluting stents (DES), which have been developed to improve bare 
metal stent (BMS), markedly reduce early restenosis to a greater extent than BMS by 
eluting drugs from active coating of stent surfaces [2.11]. On the other hands, passive 
coating such as carbon or silicon carbide previously showed no improvement of in-stent 
restenosis compared with BMS in clinical studies [2.12, 13], although they got attraction 
as the antithrombotic coating. Therefore, active coating for stent has caught the attention 
more than passive coating because of its effectiveness to restenosis. However, 
preliminary clinical studies showed potential risks of the complication in DES 
implantation. The risk of late thrombosis (up to 1 year) or very late thrombosis (after 1 
year) still remains due to delayed re-endothelialization and inhibition of vascular repair 
caused by antiproliferative agents released from DES for the prevention of smooth muscle 
cell proliferation [2.14, 15]. Furthermore, it results in long-term dual antiplatelet therapy 
after DES implantation, and this becomes the risk of bleeding [2.16].  
Therefore, newly designed stents may become an alternative method to DES 
implantation in certain patient groups. Recently, metal stent with a passive coating has 
showed very good results in clinical tests owing to development of coating technology 
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[2.17, 18]. Therefore, passive coating with antithrombogenic properties and endothelium 
compatibility is expected to develop a new stage of stents. As platelet adhesion is directly 
related with thrombus formation on stent surface, passive coating, which serve as barrier 
to platelet adhesion, can be ideal passive stent coating for novel stents. Although there 
are various kinds of passive coatings such as silicon carbide or titanium alloy, 
hydrogenated amorphous cargbon (a-C:H) which are often known as diamond-like 
carbon (DLC) is a promising passive coating and widely studied as passive coating 
materials. Amorphous carbon (a-C) has already used for not only endovascular stent but 
also implantable medical devices employed in the fields of cardiology [2.19-21], and 
highly functionalized a-C are developed as prospective passive coating. 
The fluorine-incorporated hydrogenated amorphous carbon (a-C:H:F) film is also a 
candidate of passive coating for vascular stents. For the application of a-C:H:F coating to 
intravascular stents, adhesion of a-C:H:F films on metallic stent is improved by 
introducing interlayers with controlled surface free energies [2.22]. Figure 2.1 shows 
balloon-expandable and self-expandable stents coated with a-C:H:F coatings. 
 
Figure 2.1. The a-C:H:F (F-DLC) coated stents: (a) balloon-expandable stent and (b) 
self-expandable stent.  
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2.1.3. The a-C:H:F film preparation on flat substrates for time course analysis 
after storage for a month 
   Preclinical tests and clinical trials are indispensable for verification of the stability of 
new medical devices implanted into the human body, because their usage environment in 
the human body is much tougher than that in atmospheric conditions. In addition, 
deterioration of the product before implantation should be avoided and the stability of 
biomaterials and medical devices in atmospheric condition should be ensured for 
commercialization. Regarding a-C:H:F film, Koshel et al. reported that fluorine content 
and the contact angle of the film decreased over a time course of 4 months [2.23]. Taking 
into account the commercial reality of a-C:H:F-coated stents for cardiovascular diseases, 
it is necessary to estimate the sustainability of antithrombogenic properties of them.  
   To estimate the long-term effects of expected levels of stress and lifespan of products 
in shelf life within a shorter time, accelerated aging tests are commonly used to accelerate 
the aging speed of products under suitable aggravated conditions of heat, humidity, 
sunlight, , vibration, etc. Thermal accelerated aging tests under elevated temperature are 
usually used to establish the lifespans of materials to simulate the long-term aging process 
of many devices or applications [2.24-26]. According to the technical information report 
17 published by the Association for the Advancement of Medical Instrumentation, a 
thermal accelerated aging test is also used to establish the lifespans of biomaterials.  
   To the best of our knowledge, no thermal aging test using antithrombogenic a-C:H:F 
film by time course and elevated temperature has yet been analysed or reported. Thus, in 
this study, as an aging test for a-C:H:F film under various temperature conditions, the 
antithrombogenicity and adhesive properties to SUS316L stents were evaluated for 
commercialization.   
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2.2 Materials and Methods 
2.2.1 The a-C:H:F film preparation on flat substrates for time course analysis 
after storage for a month 
2.2.1.1. The a-C:H:F film preparation methods for flat substrates 
   The a-C:H:F film was deposited on silicon flat substrates (10 × 10 mm2) to analyze 
change in film properties. To improve the adhesion strength between a-C:H:F film and a 
substrate, interlayers should be introduced. In a previous study, we revealed that two 
interlayers, hydrogenated amorphous silicon carbide (a-SiC:H) and silicon-incorporated 
a-C:H (a-C:H:Si) films, dramatically improved adhesion of a-C:H:F film to metallic 
(SUS316L) stents [2.22]. We had also proved that adhesion of a-C:H:F to the stents was 
further strengthened by a-C:H:Si film with gradient Si content. Therefore, in this study, 
on the basis of the concept of introducing interlayers for better adhesion between a-C:H:F 
film and a substrate, a three-layered film, a-C:H:F/a-C:H:Si with gradient Si content/a-
SiC:H from top to bottom, was prepared on silicon flat substrates (10 × 10 mm2). The 
thickness of a-C:H:F, a-C:H:Si with gradient Si content, and a-SiC:H films was about 200, 
100, and 100 nm, respectively. This was performed using radio frequency plasma 
enhanced chemical vapor deposition (RF-PECVD) equipment (YH-100NX, Onward 
Giken Co., Ltd., Japan) for aging tests.  
   The gas used in the a-SiC:H film deposition process was tetramethylsilane (TMS, 
Shin-Etsu Chemical Co., Ltd., Japan), and the films were deposited at a flow rate of 5.0 
sccm at a bias voltage of -2.5 kV for 630 seconds. The a-C:H:Si films were deposited on 
the flat silicon substrates from a mixture of TMS and acetylene (C2H2, Koatsu Gas Kogyo 
Co., Ltd., Japan) gas using the RF-PECVD equipment. The TMS flow rate was fixed at 
6.0 sccm and the C2H2 flow rate was changed from 0.0 sccm to 15.0 sccm gradually at a 
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bias voltage of -2.5 kV for 850 seconds.  
   For the a-C:H:F film deposition (outermost surface), a mixture of C2H2 and 
perfluoropropane gas (C3F8, Iwatani Corp., Japan) was used, and the flow rates of C2H2 
and C3F8 were 5.0 sccm and 50.0 sccm, respectively. The deposition was carried out at a 
bias voltage of -1.0 kV for 930 seconds. After deposition, the samples were stored for a 
month at various temperatures (room temperature (RT), 55°C, 70°C and 90°C).  
 
2.2.1.2. X-ray photoelectron spectroscopy (XPS) analysis on a-C:H:F-coated 
flat substrates before and after storage for a month at various temperatures 
   Chemical compositions and bonding states of the surfaces of a-C:H:F films on 
samples were measured by XPS (JPS-9010TR, JEOL Ltd., Japan). The X-ray 
photoelectron of C1s, F1s and O1s spectra were measured using Mg Ka source (10 mA, 
10kV) to evaluate surface defluorination and oxidation of a-C:H:F films. The carbon, 
fluorine and oxygen concentration of the film surface was calculated from each peak area 
and corresponding relative sensitivity factors. Decrease and/or increase of fluorine and 
oxygen were determined by the comparing F/C and O/C ratios for each concentration. 
 
2.2.1.3. Contact angle measurements on a-C:H:F-coated flat substrates before 
and after storage for a month at various temperatures 
   The wettability of the film was evaluated by measuring the static contact angles of 
droplets of distilled water (2 µL each) on sample surfaces. The contact angle 
measurements were conducted using the sessile drop method with a contact angle meter 
(DM 500, Kyowa Interface Science Co., Ltd., Japan) at five different points on each 
sample surface.  
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2.2.1.4. Human platelet adhesion and activation on a-C:H:F-coated flat 
substrates before and after storage for a month at various temperatures 
   Platelet adhesion and activation on foreign surfaces plays a central role in thrombosis. 
Platelet adhesion and activation must be assessed to determine the blood compatibility of 
a new material. In this thesis, antithrombogenic properties were evaluated by platelet 
adhesion tests. The research protocol of the platelet adhesion test in this thesis was 
authorized by the ethics review committee of Tokai University. 
   Human whole blood (85 mL) was collected from healthy volunteers who had not 
taken any medication for at least 10 days. After mixing the blood with 15 mL of acid-
citrate-dextrose (ACD), platelet-rich plasma (PRP) was isolated by centrifugation at 350 
× g and 20°C for 15 minutes. Supernatant plasma was collected as PRP, and subsequently 
remaining blood was centrifuged at 1000 × g and 4°C for 10 minutes to obtain platelet 
poor plasma (PPP). The density of platelets in PRP was adjusted to ~3.0 × 105/µl by 
dilution with PPP.  
After rinsing with phosphate-buffered saline (PBS; pH 7.4), samples were incubated 
in 24-well plates containing 1 mL of adjusted PRP at 37°C for 60 minutes in an 
atmosphere containing 5% CO2 gas. Thereafter, PRP was discarded and the samples were 
washed with PBS. Adherent platelets on samples were then fixed for 6 hours at room 
temperature in 0.8 mL of freshly prepared 1.0% glutaraldehyde in PBS. After fixation, 
the samples were washed and dehydrated in a graded ethanol series (20%, 40%, 60%, 
80%, 90%, 100% and 100% for 10 minutes each). The dehydrated samples were observed 
via differential interference contrast microscopy (BX63, OLYMPUS Co., Japan). 
Adherent platelets were manually counted on photographs of samples, and the number 
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per unit area (12,800 µm2) was calculated (n = 10). 
 
2.2.2. Observation of a-C:H:F coated-metallic stent surfaces after expansion 
using balloon catheters (after storage for two months at various temperatures)  
   The same three-layered film described in 2.1 was deposited on commercially 
available SUS316L coronary stents (KW39 [2.23], Kawasumi Laboratories, Inc., Japan) 
for evaluating adhesive change before and after for a-C:H:F coated-metallic stents over 
two months. Each SUS316L coronary stent had an inner diameter of 1.3 mm and an outer 
diameter 1.5 mm. After storage for two months at each temperature, the a-C:H:F-coated 
stent was expanded from an inner diameter of 1.3 mm to 3.5 mm using a balloon catheter. 
The balloon was inflated at a nominal pressure of 10 atm and kept inflated for 30 seconds, 
as it would be in a clinical setting. To investigate whether cracks or delamination had 
occurred, the three-layered coated-stent was examined before and after balloon-
expansion under a scanning electron microscope (SEM: SIRION, FEI Co., U.S.A.). 
 
2.2.3. Statistical analysis 
   Software (SPSS 23.0, IBM Co., U.S.A.) was used for the statistical analysis. The 
results are expressed as the mean values with the corresponding standard deviation. For 
statistical analysis of contact angle and adhesive platelet number, quantitative variables 
were compared using one-way ANOVA with post hoc Tukey’s test. The differences were 
considered statistically significant when the p value was less than 0.05. 
  
Chapter 2 
 29 
2.3 Results & Discussion 
2.3.1. Time course analysis of the a-C:H:F-coated flat substrates for a month 
2.3.1.1. Chemical composition and bonding on a-C:H:F-coated flat substrates 
via XPS 
   The time course of element concentration of a-C:H:F film was recorded within 30 
days (Figure 2.2). Figure 2.2(a) shows the relationship between time course and 
fluorine-to-carbon (F/C) ratio at each temperature (RT, 55°C, 70°C and 90°C) within 30 
days. Figure 2.2(b) shows the relationship between time course and oxygen-to-carbon 
(O/C) ratio at each temperature (RT, 55°C, 70°C and 90°C) within 30 days. Although the 
F/C ratio was constant at room temperature, the decrease of F/C ratio (defluorination) 
occurred as time passed at the conditions of high temperature (55°C, 70°C and 90°C). On 
the other hand, the increase of the O/C ratio (oxidation) gradually occurred within a 30 
days at each temperature (RT, 55°C, 70°C and 90°C). The higher the temperature is, the 
greater the extent of F/C or O/C ratio change is.  
   Figure 2.3 shows separated C1s spectra of each sample after storage for a month at 
various temperatures (room temperature (RT), 55°C, 70°C and 90°C). These results 
showed an increase in the C-C (sp2) bond spectrum and a decrease in the C-CF, C-F and 
C-F2 bond spectra at higher temperatures. These phenomena were similar to the surface 
chemical structure changes (i.e., decrease of C-Fx bonds and increase C-C and C-H bonds) 
after thermal annealing [2.27]. These results showed that chemical composition of a-
C:H:F surface aged with ambient temperature and time course. 
  In the atomic network of amorphous carbon, there are small sp2 carbon clusters 
bonding to each other via sp3 bonds or to polymeric sp3 bonds [2.28]. Although a-C:H:F 
has basically the same structure as amorphous carbon, when fluorine is incorporated in 
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amorphous carbon, it takes the place of hydrogen. In the film, such a substitution is 
responsible for changes of the carbon network. Such changes are an increase of sp2 bonds 
and sp2 clusters such as rings or chains in the carbon network or formation of sp3 
fluorocarbon bonds and a polymer-like structure [2.29-32]. D’Agostino et al. proposed 
that fluorine radicals or ions are largely trapped in these carbon networks during the 
growth of the film [2.33]. In respect to defluorination, some papers have reported that 
thermal annealing (up to hundreds of degrees centigrade) induces thermal outgassing, 
which occurs due to removal of such free radicals and unstable or weakly bonded 
fragments trapped in the sp2 clusters and cross-linked polymer chains [20, 27]. In our 
study, we considered that the F/C ratio decreased at the higher temperature conditions 
due to existence of a similar phenomenon as that in the thermal annealing situation 
(Figure 2.2(a)). In respect to oxidation, Yang Yun et al. reported that the a-CFx film 
deposited from the graphite target is comprised of CF4 gas, which is easily oxidized 
during exposure to atmospheric pressure air for an hour at 300 K [28]. They also 
suggested that the result was not related to water vapor but oxygen in air. In our study, 
increase of the O/C ratio for a month (Figure 2.2(b)) similarly results from the oxidation 
of film due to exposure of a-C:H:F film to oxygen in air. Moreover, in our study, the 
proportion of variations of F/C and O/C ratio to ambient temperature and time course was 
confirmed. The defluorination and oxidation over time are explained by reaction kinetics, 
while the changes of increment or decrement by temperature conditions are explained by 
the Arrhenius equation.  
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Figure 2.2. (a) F/C ratio and (b) O/C ratio of a-C:H:F films surface for 1 month at RT 
(Room Temperature), 55°C, 70°C and 90°C. 
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Figure 2.3. Peak separation of C1s XPS spectra after storage for 1 month at (a) RT, (b) 
55°C (c) 70°C and (d) 90°C.  
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2.3.1.2. Contact angle measurements on a-C:H:F-coated flat substrates  
   Contact angles of a drop of distilled water (2 µL) on test samples are shown in Figure 
2.4.  
 The contact angles were significantly lower for stored samples at RT (88.1° ± 1.3°), 
55°C (89.1° ± 1.2°), 70°C (90.3° ± 0.7°) and 90°C (88.6° ± 1.1°) than for the as-deposited 
sample (96.1° ± 1.5°) (p < 0.05). On the other hand, there were no statistical differences 
in contact angles among any stored samples over a month.  
   We previously reported that C-F and C-CF bonds on the topmost surface of a-C:H:F 
film with higher fluorine concentration made the surface free energy lower, and 
consequently made the contact angle higher [2.34]. In this study, however, there were 
almost no differences in contact angles among any of the stored samples, while there were 
differences in the F/C ratios for the samples. This means that the defluorination of a-
C:H:F film over time hardly affected surface free energy or wettability. Our 
understanding of these results may be supported by considering what determines contact 
angle. Contact angle was essentially influenced by surface free energy determined by 
intermolecular force. Although XPS measurements show element concentration and 
atomic bonds in material surface (several nanometers to 10 nanometers) [2.35], 
intermolecular force is mostly determined by atomic bonds in topmost surface (several 
angstroms) [2.36]. Therefore, it seems that the topmost surface chemical structure and 
chemistry were not changed, and the surface free energy of each sample remained 
consistent in the present study. It is considered that defluorination was only caused by 
outgassing of fluorine radicals or ions trapped inside a-C:H:F film surface. Consequently, 
there were no statistical differences among contact angles for any stored samples over a 
month at various temperatures. We think that the situation of defluorination from the a-
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C:H:F surface is fundamentally different from that of fluorine-doping during the film 
deposition. 
 
 
 
 
Figure 2.4. Contact angle as-deposited and stored for 1 month at RT, 55°C, 70°C and 
90°C.  
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2.3.1.3. Antithrombogenic tests on a-C:H:F-coated flat substrates 
   An antithrombogenic test was performed on each sample. After storing samples at RT, 
55˚C, 70˚C and 90˚C for a month, each sample and a fresh sample were tested. Figure 
2.5 shows images of adherent platelets observed through differential interference contrast 
microscopy. The number of platelets on each sample was counted on each photograph, 
and the statistical results are shown in Figure 2.6. Compared with the fresh sample, no 
sample showed reduction of antithrombogenic properties.  
   Although platelet adhesion has tendency to be affected by contact angle, the reduction 
of the contact angle from as-deposited to stored samples did not promote the adhesion of 
platelets in this study. Previously, we reported that the lower contact angle as fluorine 
concentration affects adsorption of plasma proteins on foreign surfaces [2.37]. The 
proteins “albumin and fibrinogen” in blood plasma determined the interaction between 
platelets and foreign materials. Specifically, a higher ratio of albumin/fibrinogen 
corresponds to a lower number of adherent platelets on the sample surfaces. The adhesion 
of platelets on a-C:H:F film, which is a hydrophobic surface, is drastically suppressed, 
because the ratio of albumin/fibrinogen is very high compared with the other sample 
surfaces. However, small differences in contact angles among the test samples have an 
insignificant effect on the degree of platelet adhesion [2.37]. In our study, there was no 
significant difference between the number of adherent platelets on samples as-deposited 
and those stored at each temperature for a month. This suggests that the reduction of 
contact angle from “as-deposited” was sufficiently low and plasma proteins were almost 
equally adsorbed on each sample even after storage for a month at each temperature. 
These results also showed that defluorination caused by outgassing of fluorine might not 
degrade the antithrombogenic properties of a-C:H:F film.  
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Figure 2.5. Adhesive platelets images (a) as-deposited, stored for 1 month at (b) RT, (c) 
55°C, (d) 70°C and (e) 90°C. 
  
Chapter 2 
 37 
 
 
 
 
 
Figure 2.6. Number of adhesive platelets; as-deposited and stored for 1 month at RT, 
55°C, 70°C and 90°C.  
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2.3.2. Coating adhesion tests on a-C:H:F coated stents 
   After storage for 2 months, the a-C:H:F coated stents expanded with balloon catheters 
were observed using SEM (Figure 2.7). There were no cracks or instances of 
delamination on any stent surfaces, regardless of thermal change. Although it was 
reported that the internal stress of a-C:H:F film changes after outgassing of radicals and 
ions [2.27], the property of adhesion to stents was not influenced by changes in the 
temperature or passage of time in this study. Thus, the sufficient stability of adhesive 
properties on metallic stents was revealed. For long time, usefulness of passive stent 
coating has been neglected, because stents covered with DLC or silicon carbide had not 
improved in-stent restenosis [2.12, 13]. However, it has become apparent that passive 
coating suppresses complications on bare metal stents, as coating technology has 
developed [2.17, 18]. In recent year, Orsiro stent (Biotronik, Berlin, Germany), which is 
a hybrid combination of passive and active coatings with the aim of optimizing clinical 
effectiveness and mitigating the risk of late events, demonstrated potency with low rates 
of in-stent restenosis and was associated with a reduced risk of late stent thrombosis [2.38, 
39]. Therefore, it is expected that stents with hybrid coating changes the state of stent 
implantation and much is also expected of DLC family as a passive coating of hybrid 
combination. 
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Figure 2.7. SEM images of expanded KW39 coronary stents after storage for 2 months 
at RT, 55°C, 70°C and 90°C. 
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2.4. Conclusions 
   In this study, we tried to reveal the aging of a-C:H:F film using accelerated aging tests, 
especially focusing on surface chemistry, contact angles of surfaces, antithrombogenic 
properties and adhesive properties. Consequently, defluorination and oxidation were 
confirmed on surfaces of a-C:H:F film stored at high temperatures (55°C, 70°C and 90°C) 
after a month. These seem to be caused by outgassing of trapped fluorocarbon radicals 
and fragments in a carbon network of a-C:H:F film and oxygen in the air, respectively. 
Although these factors result in changes of element concentration, they are not considered 
as problematic in terms of commercialization. This is because aging tests did not indicate 
deterioration of wettability, antithrombogenic properties or adhesive properties. Although 
a detailed investigation will be needed to clarify the mechanism of chemical structure 
changes and properties after longer-term storage, the acceptable stability of a-C:H:F 
three-layered film was determined in the present study for future application as 
antithrombogenic coatings for medical devices. 
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Chapter 3 
The a-C:H:F coating for suppressing adhesion of embolic glue 
(N-butyl-2-cyanoacrylate) 
 
3.1 Introduction 
Transcatheter arterial embolization has gained widespread acceptance for the 
treatment of arterial disorders such as arterial bleeding arteriovenous fistulae, raptured 
aneurysm, and arteriovenous malformation [3.1, 2]. N-butyl-2-cyanoacrylate (NBCA), 
which is a polymerizing adhesive, has been used as a common liquid embolization 
material to treat the arterial diseases [3.1, 3, 4]. NBCA is an effective monomer liquid 
which rapidly forms polymer structure with strong adhesive bonds when contacting with 
ionic mediums such as blood.  
However, since NBCA instantly polymerizes upon contact with blood, there is a 
problem that the catheters which is a medical device adheres to NBCA. Its exceptionally 
strong adhesive force sometimes causes nontarget vascular occlusion or unintended 
adhesion between tip of the catheter and artery. For a long while, many researchers have 
reported new techniques or technologies to overcome these problems. For example, 
balloon-occluded glue embolization (B-Glue) is a brand-new technique that enables to 
handle N-butyl-2-cyanoacrylate (NBCA) as a liquid embolization material relatively 
easier and safer under balloon occlusion status. However, adhesion of balloon and NBCA 
remains   
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To overcome the problem, fluorine-incorporated hydrogenated amorphous carbon (a-
C:H:F) is focused as a coating which decreases of surface adhesiveness and improves 
blood compatibility. The a-C:H:F is studied as a candidate of anti-sticking layer which is 
used for lithography technologies to prevent the adhesion between molds and replication 
materials [3.5, 6]. Therefore, a-C:H:F coating on catheters can be effective method to 
suppress NBCA adhesion with catheters. However, the direct deposition of a-C:H:F onto 
polyurethane (PU) as a catheter material leads to poor coating adhesion. Purposes of this 
study are to improve the adhesive property of a-C:H:F film on PU by plasma treatment 
and evaluate the adhesiveness of a-C:H:F to NBCA.  
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3.2. Materials and Methods 
3.2.1. Sample preparation: Plasma treatment of polymer substrates and 
deposition of amorphous carbon films on them 
The polyurethane (PU) substrates of about 200 µm thickness were treated with Ar 
plasma using RF-CVD. The RF (13.56 MHz) power and total pressure were fixed at 200 
W and 13.3 Pa, respectively. PU substrates were exposed to Ar plasma for 0–300 s. After 
modifying PU surface by Ar plasma, a-C:H:F films were deposited on PU substrates using 
(RF-PECVD) equipment (YH-100NX, Onward Giken Co., Ltd., Japan) on the basis of 
our previous study. For the a-C:H:F film deposition, a mixture of acetylene (C2H2: Koatsu 
Gas Kogyo Co., Ltd., Japan) and  (C3F8: Iwatani Corp., Japan) gas was used, and the 
flow rates of C2H2 and C3F8 were 5 sccm and 50 sccm, respectively. 
 
3.2.2. Characterizations of the plasma treated PU substrates 
After the plasma treatment on the PU substrates, surface chemical compositions were 
measured by X-ray photoelectron spectroscopy (XPS, JPS-9010TR, JEOL Ltd., Tokyo 
Japan). In this study, Ar plasma treated PU substrates before and after being coated by a-
C:H:F film were analyzed via XPS measurement, and then a-C:H:F coated PU samples 
X-ray source was Mg Kα, and the spectral regions used for the measurement were C1s, 
O1s, and F1s.  
 
3.2.3. Surface roughness and surface morphology of plasma treated PU 
substrates 
The surface roughness of PU and a-C:H:F film coated PU substrates was examined 
by dynamic mode atomic force microscopy (AFM; SPM-9700, Shimadzu Corp., Japan) 
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using a scan area of 10×10 µm2. The measurements of surface roughness were performed 
at 5 different surface locations and representative three-dimensional images of each 
sample were observed. Furthermore, scanning electron microscopy (SEM; S-4700, 
Hitachi High-Technologies Corp., Japan) was also used to observe surface morphology 
of plasma treated PU surface.  
 
3.2.4. Contact angle measurement 
The wettability and surface free energy of the a-C films were evaluated by measuring 
the static contact angles between a droplet (2.0 µL) of distilled water and diiodomethane, 
and the sample surface at room temperature. The values of the water contact angle are the 
average of 10 samples. Contact angle measurements were conducted using a sessile drop 
method with DM 500 (Kyowa Interface Science Co., Ltd., Japan). 
 
3.2.5. Adhesive and deformation following properties of a-C:H:F films on PU 
substrates  
There are many methods to evaluate adhesive properties between thin film and mated 
substrates. In current study, film adhesive strength was measured using a scratch testing 
equipment (CSR 2000, Rhesca Co., Japan), and tensile test was also used for evaluating 
deformation following properties with tensile tester (AG-50NIS MS, Shimadzu Co., 
Japan). 
 
3.2.6. Antithrombogenic tests 
Human whole blood (90 mL) was collected from healthy volunteers who had not 
taken any medication for at least 10 days and mixed with 10 mL of acid–citrate–dextrose 
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(AC-D). Following this, the blood was centrifuged at 350 × g for 15 min to separate the 
blood corpuscles, and thus the resulting platelet-rich plasma (PRP) was prepared. 
Subsequently, a portion of the PRP was centrifuged at 1000 × g for 10 min to obtain the 
platelet-poor plasma (PPP). The density of platelets in PRP was adjusted to 3.0 × 105/µl 
by dilution with PPP. Sample disks (surface area of 10 × 10 mm2; n = 3 disks per sample), 
a control (polycarbonate), Si substrate coated with a-C:H, and Si substrate coated with H-
free a-C were washed with phosphate-buffered saline (PBS) at pH 7.4 and then incubated 
in 24-well plates containing 1 mL of adjusted PRP at 37 °C for 60 min in an atmosphere 
containing 5.0% CO2 gas. Thereafter, the supernatant was discarded, and the samples 
were washed with PBS. The adherent platelets were then fixed for 60 min at room 
temperature in 0.8 mL of freshly prepared 1.0% of glutaraldehyde. After fixation, the 
samples were naturally dried and dehydrated. The entirely dried materials were examined 
using differential interference contrast (DIC) microscopy (Nikon ECLIPSE L150, Tokyo, 
Japan) and SEM. Adhering platelets were manually counted using photographs, and the 
number per unit area (10800 µm2) was calculated.  
 
3.2.7. Adhesive tests between a-C:H:F coated PU and NBCA 
Tensile shear test was conducted to evaluate adhesive properties between NBCA and 
each sample based on JIS K 6861 and previous study [3.7]. To determine shear stress, we 
prepared untreated PU, PU coated with H-free a-C (no pretreatment), Ar-plasma-treated 
(300 s) PU coated with a-C:H:F. We also prepared hydrophilic treated polycarbonate (PC) 
and dipped them into distilled water. All samples were cut into portions with areas of 30 
× 70 mm2 and then tested, as per the standard procedure provided by JIS K 6861 (The 
length was slightly modified to fit the chamber of our RF-CVD system.). The PC and PU 
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substrates were attached via 2 µL of NBCA. The tensile test was carried out using the 
tensile tester described above. Two free edges of one sample were grasped by two clamps 
of the tensile tester. The lower clamp was settled at the same position and the upper clamp 
was free to move upward at a predefined velocity of 10 mm/min.  
 
3.2.8. Statistical analysis 
SPSS software version 23 was used for statistical analysis. The results were expressed 
as the mean values with the corresponding standard deviation. For statistical analysis, 
quantitative variables were compared via t-test. The differences were considered to be 
statistically significant when the p value was less than 0.05.  
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3.3. Results 
3.3.1. Surface chemical composition of polyurethane 
Figure 3.1 shows O/C and N/C ratios of the polyurethane surface after Ar plasma 
surface treatment. At etching on PU surface resulted in increase of O/C ratio only, and 
surface treatment time affected the amount of O/C ratio increase but N/C ratio. By Ar 
etching, O/C ratio apparently increased from 30 s to 120 s compared with non-treated PU. 
Although O/C ratio increased by Ar etching for 30–120 s, the ratio did not increased by 
Ar etching more than 120 s. Figure 3.2 shows C1s spectrum of plasma treated PU 
surfaces. Whereas the C-C bond peak (284 eV) decreased by Ar-plasma treatment, C-O 
bond peak (286 eV) were shown in PU treated by Ar plasma. 
In the plasma treatment with an inert gas such as Ar, the action of physical etching, 
not chemical etching, is mainly influenced. However, previous studies reported that 
surface treatment of polymer materials by plasma of inert gases such as He and Ar leads 
to increase of surface oxygen concentration by introducing C-O, C=O, of O-C=O bonds 
[3.8, 9]. It is considered that structure of the polymer stabilized by rearrangement of PU 
surface and surfaces were oxidized by the reaction with oxygen and carbon radicals on 
the surface in atmosphere after chemical bonding on the surface is cut by physical etching 
of Ar plasma, because Ar plasma etching causes ablation of C-C or C-H bonds on polymer 
surface. In this study, the oxidation after physical etching by Ar plasma would contribute 
to introduce oxygen on PU surface. 
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Figure 3.1. O/C and N/C ratios of Ar plasma treated PU surfaces. 
 
 
 
Figure 3.2. C1s XPS spectra of Ar plasma treated PU surfaces. 
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3.3.2. Surface roughness  
The surface roughness (Ra) and surface morphology were observed on PU substrates 
treated by Ar plasma and coated by a-C:H:F using AFM. The numbers of Ra are shown 
in Figure 3.3 and the three dimensional images of each surfaces are shown in Figure 3.4 
and 3.5, and SEM images are shown in Figure 3.6 and 3.7. 
In Ar plasma treated PU, unevenness without regularity was confirmed, and fine 
unevenness was confirmed in PU treated by Ar plasma for 30 and 60 seconds as compared 
with the 0 second sample. However, in the PU treated by Ar plasma for 120 and 300 
seconds, roughness was hardly confirmed. Unevenness of the surface increased by 
depositing a-C:H:F at all PU samples without Ar plasma treatment time. In the Ar plasma-
treated PU for 30 and 60 seconds, no significant change was observed in the surface shape, 
but the surface changed into spherical projection shape by applying Ar plasma treatment 
for 120 and 300 seconds. The diameter of the protrusion was about 50 nm. PU is a 
crystalline polymer [3.10]. The crystalline polymer has a structure both crystal portion 
and  amorphous portion. It is known that it selectively etches a soft amorphous portion 
as compared with the crystal portion when crystalline polymers are treated by inert gas 
plasma such as Ar. In this study, spherical shape was generated by selectively etching 
amorphous portions by Ar plasma treatment to crystalline polymer PU. 
The a-C:H:F coated on PU treated by Ar plasma for 30 and 300 seconds on showed a 
wrinkle shape. Furethermore, a-C:H:F coated PU (Ar120 and 300) had spherical 
protrusions derived from the surface of PU treated by Ar plasma. Furthermore, from the 
SEM image of low magnification, the surface changed to wrinkle shape by a-C:H:F 
coating. 
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Figure 3.3. Surface roughness of PU surfaces after Ar plasma treatment and a-C:H:F 
coating. 
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Figure 3.4. The 3D surface images of PU surfaces after Ar plasma treatment for  
(a) 0 sec, (b) 30 sec, (c) 60 sec, (d) 120 sec, and (e) 300 sec. 
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Figure 3.5. The 3D surface images of PU surfaces coated by a-C:H:F film after Ar 
plasma treatment for (a) 0 sec, (b) 30 sec, (c) 60 sec, (d) 120 sec, and (e) 300 sec. 
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Figure 3.6. SEM images of PU surfaces after Ar plasma treatment for (a) 0 sec, (b) 30 
sec, (c) 60 sec, (d) 120 sec, and (e) 300 sec.  
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Figure 3.7. SEM images of PU surfaces coated by a-C:H:F film after Ar plasma 
treatment for (a) 0 sec, (b) 30 sec, (c) 60 sec, (d) 120 sec, and (e) 300 sec. 
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3.3.3. Wettability  
The surface free energy of Ar-etched PU and a-C:H:F-coated PU were shown in 
Figure 3.8. The surface free energy of each sample was calculated from contact angles 
of water and diiodomethane on them. Although the contact angle of distilled water was 
reduced by Ar-plasma treatment, the contact angle did not change significantly depending 
on the treatment time, and it was 64.5 ± 2.4° for PU treated by Ar plasma for 300 seconds. 
The contact angle of diiodomethane decreased with the Ar plasma treatment time and in 
the PU treated by Ar plasma for 300 seconds it was 20.1 ± 1.0°. The contact angle of 
distilled water to a-C:H:F-coated PU was 134.7 ± 1.5° at 300 seconds. The contact angle 
of diiodomethane of a-C:H:F-coated PU (Ar300) was 100.3 ± 2.9°. Consequently, By Ar 
etching, surface free energy of PU was increased regardless of treatment time. It is 
considered that introduction of C-O bonds by Ar etching resulted in increase of surface 
free energy. 
 
 
Figure 3.8. Contact angles on Ar plasma treated PU surfaces. 
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3.3.4. Adhesive and deformation following properties of a-C:H:F films on PU 
substrates 
The a-C:H:F-coated PU substrates, which were treated by Ar plasma for 0–300 sec 
before coating, were prepared to evaluating adhesive properties of a-C:H:F and PU. 
Figure 3.9 shows results of scratch test, the peel strength of each sample. The critical 
load of a-C:H:F film on PU substrates was increased by Ar plasma etching time, there are 
no significant difference between a-C:H:F on PU (Ar120) and PU (Ar300).  
Figure 3.10 shows that clacks of a-C:H:F coating on PU substrates when being 
stretched to 50, 100, and 200% of their original length. This result showed that Ar plasma 
treatment also contributed to improve deformation following properties of PU and a-
C:H:F coating. 
Surface chemical composition, surface free energy, of surface shape can be considered 
as factors influencing the adhesion between the thin film and the film formation material 
[3.11-13]. The most important factor caused by Ar-plasma treatment is that oxygen is 
introduced to the surface and the surface free energy is increased in addition to the 
increase in the surface area due to the change in the surface shape. It is considered that 
the surface free energy mainly influenced the improvement of adhesive and deformation 
following properties. 
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Figure 3.9. Adhesive strength of a-C:H:F on Ar-etched PU surfaces. 
 
 
Figure 3.10. Deformation following properties of a-C:H:F films on Ar plasma treated 
PU. 
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3.3.5. Platelet adhesion 
   Platelets attached to the surface of the samples were observed with a differential 
interference microscope. Figure 3.11 shows the number of adherent platelets per unit area 
(10800 µm2) on PU substrates, a-C:H:F coating on untreated PU substrates (Ar 0) and a-
C:H:F coating on plasma treated PU substrates (Ar 300). There was a significant 
difference in the number of platelet adhesion between PU and a-C:H:F (Ar 0). There was 
no significant difference in the number of platelet adhesion between a-C:H:F (Ar 0) and 
a-C:H:F (Ar 300).  
   The SEM image of platelets adhering to each sample is shown in Figure 3.12. 
Platelets adhered to the whole surface and almost no spherical platelets were observed on 
PU surfaces. Furthermore, pseudopods of platelets were activated and many stretched and 
flattened platelets were observed. Although platelets were hardly observed on a-C:H:F 
coated non-treated PU (Ar 0), various morphological platelets were observed. On a-C:H:F 
coated PU (Ar 300), a lot of pseudopods expressed and extended from platelets were 
observed, and pseudopods tended to selectively extend to the brow portion of the surfaces. 
   As a result of the number of adhered platelets shown in Figure 3.11, the number of 
adherent platelets on a-C:H:F coated PU substrates decreased compared to pure PU 
substrates. Since PU is a material with excellent blood compatibility [3.14], it is 
considered that a-C:H:F has superior hemocompatibility over conventional blood 
compatible materials. In addition, no change was observed in the number of adhered 
platelets in a-C:H:F synthesized on untreated PU and on Ar plasma treated PU for 300 
seconds. It has been reported that various surface characteristics of materials affect the 
adhesion of platelets to materials, and surface roughness, wettability, etc. [3.15-17]. It has 
been reported that surface roughness does not affect the number of platelet, if the surface 
Chapter 3 
 65 
roughness Ra is 100 nm or less on a-C:H:F films [3.18]. Since the surface roughness of 
a-C:H:F coated on untreated PU and on PU treated by Ar plasma for 300 seconds was 
100 nm or less, the same phenomenon was observed in this study. 
  As shown in SEM images of adherent platelets (Figure 3.12), platelets on a-C:H:F 
deposited on PU (Ar 300) selectively extended their pseudopods and adhered to the brow 
of the wrinkle shaped on the surface. It has been shown that adhesion and activation of 
platelets differ depending on the shape of the surface even with the same material. Chen 
reported that platelet adhesion and activation behavior change by creating various 
multiscale micro/nano structures [3.19]. The surface of a-C:H:F coated PU (Ar 300) has 
a wrinkle shape with a cycle of several hundred nm and a spherical projection shape with 
a few nm. It is considered that the surface shape having a double structure generated by 
Ar plasma treatment and A-C:H:F film formation influenced the adhesion / extension 
behavior of pseudopods of platelets. 
 
 
Figure 3.11. Number of adhesive platelets on each sample. 
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Figure 3.12. SEM images of adherent platelets on (a) non-treated PU, (b) a-C:H:F 
coated PU(Ar0) and (c) a-C:H:F coated PU(Ar300). 
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3.3.6. Adhesion of NBCA on a-C:H:F coated PU 
Adhesive properties to NBCA were tested on PU substrate, a-C:H:F coated pure PU 
(Ar0), and a-C:H:F on PU (Ar300) which has the most improved adhesion of A-C:H:F 
and PU, Adhesion of PU (Ar300) coated with a-C:H:F to NBCA was evaluated by tensile 
shear test. Adhesive strength was determined from a load-elongation diagram at each 
adhesion time. The maximum load in the load-elongation diagram is taken as the adhesive 
strength between NBCA and a-C:H:F coated PU to the adhesion time of each sample in 
Figure 3.13. The adhesion strength with NBCA on PU was the largest at all adhesion 
times, and the bond strength between NBCA and a-C:H:F-coated PU (Ar0) and a-C:H:F-
coated PU (Ar 300) was comparable. Especially at an adhesion time of 120 seconds, the 
adhesion strength of the sample coated with a-C:H:F with NBCA was 10 N or less, 
whereas the adhesion strength of PU to NBCA was about 30 N. Therefore, when the 
NBCA adhesion time was 120 seconds, the bond strength with NBCA was reduced to one 
third by a-C:H:F coating. The adhesion strength of PU increased as the adhesion time 
increased. The bond strengths of a-C:H:F-coated PU (Ar0) and a-C:H:F-coated PU 
(Ar300) hardly changed until the adhesion time.  
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Figure 3.13. Adhesive strength of NBCA on a-C:H:F coated PU surfaces.  
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3.4. Conclusion 
   In this study, we tried to establish the technology to suppress NBCA adhesion with 
catheters by applying a-C:H:F coating on catheter materials. For this objective, we 
improved  the adhesive property of a-C:H:F film on PU by plasma treatment and 
evaluate the adhesiveness of  a-C:H:F-coated PU to NBCA. Consequently, PU coated 
with a-C:H:F films effectively reduce the adhesion of NBCA on themselves. Thus, the 
present study indicates that the a-C:H:F-coated Ar plasma-treated PU can serve as a 
promising candidate for catheters used to NBCA embolization technique. 
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Chapter 4 
Anti-bacterial amorphous carbon films on plasma-pretreated 
polytetrafluoroethylene (PTFE) with a-C:H:F interlayer 
 
4.1. Introduction 
Hydrogenated amorphous carbon (a-C:H) films, which consists of sp3 and sp2 carbon 
bonds that include hydrogen in their structure, have been attracting attention as a 
biomaterial, showing a number of good properties such as extreme hardness, low friction 
coefficient, high wear resistance, and good biocompatibility [4.1]. Actually, studies of 
new biomaterials proposed to enhance the antibacterial and antithrombogenic properties 
of a-C:H [4.2-4], as well as the addition of metal atoms, have been promising in terms of 
improving the antibacterial properties of a-C:H [4.5, 6]. However, these materials have 
not reached the stage of practical applications to medical devices owing to the outflows 
of metal ions and damage to living bodies. Recently, Zhou et al. have reported that 
amorphous carbon films applied to SUS with a reduced hydrogen content inhibited the 
adhesion and colonization of bacteria [4.7]. Thus, it is expected that hydrogen-free 
amorphous carbon (H-free a-C) materials would be more practical as coatings for medical 
devices.  
Polytetrafluoroethylene (PTFE) is one of the most useful biomaterials used for biliary 
tubes and covering materials for biliary stents as well as for prosthetic vascular grafts. 
However, bacterial infection through microbial adhesion and thrombus formation by the 
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adsorption of blood components on the PTFE surface are potentially serious obstacles 
[4.8-10]. Therefore, H-free a-C coated on PTFE is one of the best ways to address such 
problems. 
Generally, amorphous carbon films exhibit poor adhesion with other base materials 
used for medical implants, which causes film cracking. Some reports have revealed that 
plasma pretreatment improves the adhesion of amorphous carbon film [4.11-13]. Thus, 
appropriate deposition processing, including pretreatment, is required when amorphous 
carbon films are used for coatings. 
In our study, we measured the antibacterial and antithrombogenic properties to verify 
the biocompatibility of the H-free a-C itself. Then, to further improve the adhesive 
strength between PTFE and H-free a-C, we deposited H-free a-C onto a PTFE substrate 
using not only the plasma deposition method after Ar or O2 gas plasma treatment, but also 
the introduction of an interlayer of fluorine-incorporated a-C:H (a-C:H:F) during 
pretreatment. 
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4.2. Materials and Methods 
4.2.1. Biocompatibility tests 
4.2.1.1. Sample preparation: Deposition of amorphous carbon films 
Two types of carbon film, a-C:H and H-free a-C, were deposited on polymer and Si 
substrates. The a-C:H was deposited by radio frequency (RF) plasma-enhanced chemical 
vapor deposition (CVD) from C2H2. The RF (13.56 MHz) power and total pressure were 
fixed at 200 W and 13.3 Pa, respectively. The H-free a-C was deposited by filtered arc 
deposition (FAD). A graphite target was used as the cathode material. Deposition was 
carried out with an arc voltage and an arc current of 100 V and 40 A, respectively. The 
total pressure was fixed at 2 × 10-3 Pa. The total thickness of the carbon films was about 
50 nm. 
4.2.1.2. Characterizations of amorphous carbon films  
For characterization of amorphous carbon films, we deposited a-C:H and H-free a-C 
films on Si substrates under the condition described in sect. 4.2.1.1 to exclude the effects 
of substrates’ surface morphology and roughness. Structural information of the carbon 
films was obtained using an argon laser Raman spectrometer (NRS-2100, Jasco, Tokyo, 
Japan) and fourier transform infrared spectroscopy (FT-IR, BRUKER ALPHA-T). 
Raman spectroscopy was performed at room temperature using the 514.5 nm line from 
the Ar laser, and the laser power was kept constant at 1 mW at the sample surface. Spectra 
were recorded from 1100 to 1700 cm-1 and fitted using two Gaussian peaks after 
subtracting the background to determine the peak positions. FT-IR was employed to 
evaluate the C-H bonding state in the carbon films. The transmission spectra were 
recorded in the range of 1000–4000 cm-1. 
The surface chemical composition was measured by high-resolution elastic recoil 
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detection analysis (HR-ERDA) using 480 keV N+ ions, directed at the sample surface at 
an incident angle of 70° relative to the sample normal. The energy of the hydrogen ions, 
recoiled out of the samples, was detected using the magnetic field deflecting energy 
analyzer at a position such that the scattering angle was 30°. The exposure dose was 
determined by measuring the electric current irradiated in the pendulum, which caused 
the pendulum to vibrate within the beam path. The detection limit of each element was 
approximately 2 at.% of carbon and oxygen and 1 at.% of hydrogen. 
The wettability and surface free energy of carbon films, such as H-free a-C and a-C:H, 
were evaluated by measuring the static contact angles between a droplet (2 µl) of distilled 
water and diiodomethane, and the sample surface at room temperature. The water contact 
angles were taken from the averages of ten samples. Contact angle measurements were 
conducted by the sessile drop method with a DM 500 (Kyowa Interface Science Co., Ltd.). 
4.2.1.3. Antibacterial tests 
Escherichia coli (E. coli) was selected an indicator for experimental bacteria. We 
prepared 50 × 50 mm2 of a-C:H, and H-free a-C. Three samples were evaluated by the 
colony-counting method. All the samples were sterilized by autoclaving at 121 °C for 20 
min. A solution of bacteria in sterile phosphate-buffered saline (PBS) with a concentration 
of 5×105 CFU/mL was applied in droplets to the surface of the samples equally and evenly 
with a bacteria solution at a density of 0.5 mL per sample. Then, all the samples were 
incubated at 36 °C and > 90% RH for 24 h, as called for by the JIS Z 2801 standard. After 
the incubation, the samples were rinsed with PBS and then in soybean-casein digest broth 
with lecithin & polysorbate (SCDLP) for several seconds to wash out the bacteria that 
had become attached to the sample surface. Subsequently, serial dilutions of the extracted 
solution were spread on agar plates and incubated at 36 °C for two nights. Colonies were 
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counted visually, and the numbers of Colony Forming Unit (CFU) per sample were 
determined. 
4.2.1.4. Antithrombogenic tests 
Human whole blood (90 mL) was collected from healthy volunteers who had not 
taken any medication for at least 10 days and mixed with 10 mL of acid–citrate–dextrose 
(AC-D). Following this, the blood was centrifuged at 350 × g for 15 min to separate the 
blood corpuscles, and thus the resulting platelet-rich plasma (PRP) was prepared. 
Subsequently, a portion of the PRP was centrifuged at 1000 × g for 10 min to obtain the 
platelet-poor plasma (PPP). The density of platelets in PRP was adjusted to 3.0 × 105/µL 
by dilution with PPP. Sample disks (surface area of 10 × 10 mm2; n = 4 disks per sample), 
a control (polycarbonate), Si substrate coated with a-C:H, and Si substrate coated with H-
free a-C were washed with phosphate-buffered saline (PBS) at pH 7.4 and then incubated 
in 24-well plates containing 1 mL of adjusted PRP at 37 °C for 60 min in an atmosphere 
containing 5.0% CO2 gas. Thereafter, the supernatant was discarded, and the samples 
were washed with PBS. The adherent platelets were then fixed for 60 min at room 
temperature in 0.8 mL of freshly prepared 1.0% of glutaraldehyde. After fixation, the 
samples were washed and dehydrated in a graded ethanol series (20, 40, 60, 80, 100, and 
100% for 10 min each), as described previously [4.14]. The entirely dried materials were 
examined using differential interference contrast (DIC) microscopy (Nikon ECLIPSE 
L150, Tokyo, Japan). Adhering platelets were manually counted using photographs, and 
the number per unit area (12800 µm2) was calculated.  
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4.2.2. Film adhesion evaluation 
4.2.2.1. Sample preparation: Plasma treatment and deposition of amorphous 
carbon films 
The PTFE substrates of about 0.1 mm thickness were treated with Ar or O2 plasma 
using RF-CVD. The RF (13.56 MHz) power and total pressure were fixed at 200 W and 
13.3 Pa, respectively. The PTFE substrates were modified in Ar or O2 plasma for 30–300 
s. After the plasma treatment on PTFE substrates, interlayers of a-C:H:F on the substrates 
were deposited by RF-CVD. The a-C:H:F films were deposited on the substrates using a 
mixture of acetylene (C2H2) and hexafluoroethane (C2F6) under the same conditions as 
those used for plasma treatment. The a-C:H:F films were deposited at a partial pressure 
of C2H2 at 20% and C2F6 at 80%. Two types of carbon film, a-C:H and H-free a-C, were 
deposited on the pretreated PTFE substrates. The a-C:H films and H-free a-C films were 
deposited under the conditions described in sect. 4.2.1.1. 
4.2.2.2. Characterizations of the plasma treated PTFE and the interlayer 
After the plasma treatment and introduction of the a-C:H:F interlayer on the PTFE 
substrates, surface chemical compositions were measured by X-ray photoelectron 
spectroscopy (XPS, JPS-9010TR, JEOL Ltd., Tokyo Japan). The X-ray source employed 
here was Al Kα, and the spectral regions used for the measurement were C1s, O1s, and 
F1s. 
4.2.2.3. Adhesive tests 
A T-peel test (ISO11339:2003) was conducted to evaluate adhesive properties. To 
determine peel strength, we prepared untreated PTFE directly coated with H-free a-C (no 
pretreatment), O2- or Ar-plasma-treated PTFE directly coated with H-free a-C [O2 (no 
interlayer) and Ar (no interlayer), respectively]. and O2- or Ar-plasma-treated PTFE 
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coated with H-free a-C [O2 (no interlayer) and Ar (no interlayer), respectively]. Each 
sample was bonded using epoxy resin (Devcon S-31, ITW Industry Ltd.). The samples 
were then pressed at 5 MPa at room temperature for 300 s to remove any trapped air at 
the adhesive interface. The pressed samples were then placed in an oven set at 50 °C to 
accelerate the hardening of the epoxy adhesive. After hardening, the samples were cut 
into portions with areas of 100 × 25 mm2, as per  the standard procedure provided by 
ISO. (The length was slightly modified to fit the chamber of our RF-CVD system.) The 
T-peel test was carried out using a tensile tester (AG-50NIS MS of Shimadzu 
Corporation). Two free edges of one sample were grasped by two clamps of the tensile 
tester. The lower clamp was settled at the same position and the upper clamp was free to 
move upward at a predefined velocity of 10 mm/min provided by ISO. 
 
4.2.3. Statistical analysis 
SPSS software version 22 was used for statistical analysis. The results were expressed 
as the mean values with the corresponding standard deviation. Comparisons of the peel 
strength of each sample in plasma treatment time were analyzed using one-way ANOVA 
with post-hoc Dunnett’s test. For statistical analysis, quantitative variables were 
compared via t-test. The differences were considered to be statistically significant when 
the value of p was less than 0.05. 
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4.3. Results and Discussion 
4.3.1. Characterizations of amorphous carbon films 
Figure 4.1 shows structural information on the samples after the deposition of carbon 
films by Raman spectroscopy. There were two peaks: the D-peak (1350 cm−1) and the G-
peak (1530 cm−1), which indicate a representative diamond-like carbon film, in the 
Raman spectrum of both a-C:H and H free a-C. 
Figure 4.2 shows the chemical structure of carbon films observed by FT-IR. 
According to the study of Zhou et al., as the peak meant -CH3 (2870 cm−1) and -CH2 
(2925 cm−1 and 2950 cm−1), this is direct evidence of the existence of hydrogen.(7) The 
FT-IR spectrum of H-free a-C was quite flat in the range of 1000–4000 cm−1. On the other 
hand, there was a peak at 2910 cm−1 in the FT-IR spectrum of a-C:H. We speculated that 
the peak at 2910 cm−1 was a complex formed of peaks of -CH2 and -CH3. Therefore, as 
the peak was observed for the a-C:H in our study, the presence of C-H bonds on the a-
C:H was confirmed, and because no peak was observed for the H-free a-C in our study, 
the suppression of C-H bonds on the H free a-C was confirmed. 
Except for a contaminated layer, the surface chemical composition of the a-C:H of 
our study consisted of 60.1 at.% carbon, 39.9 at.% hydrogen and 0.0 at.% oxygen on HR-
ERDA. On the other hand, H-free a-C of our study consisted of 100 at.% carbon on HR-
ERDA. Such results directly indicated that there was no hydrogen on the H-free a-C in 
our study. 
Table 4.1 shows the water contact angle and surface free energy of carbon films. The 
denotation “θw” represents the contact angle (°). γs, γsp, and γsd represent the surface free 
energy and its polar and dispersive components with reference to the carbon films, 
respectively. The value of θw on H-free a-C was 69.0° and on a-C:H, it was 65.9°. The 
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water contact angle of amorphous carbon films depends on surface roughness and surface 
chemical composition. As two carbon films, H-free a-C and a-C:H are very smooth [i.e., 
when deposited on Si substrate, surface roughness (Ra) was less than 1 nm], and the water 
contact angle has no decisive effect on the surface roughness in this study. Surface 
chemical composition difference between a-C:H and H-free a-C was exhibited by the 
existence (or lack thereof) of an C-H bond in the film. According to Ma et al., C-H bonds 
are characteristic of ‘‘oil,’’ which is hydrophobic in nature[4.15]. However, as reported 
previously, the water contact angle of H-free a-C is greater than 80° [4.16]. Therefore, the 
result of wettability depends on deposition condition or film formation equipment, and 
the water contact angle of our H-free a-C was 69.0°. In addition, the water contact angle 
of our a-C:H film was 65.9°, and the result was similar to that measured by our group[4.17, 
18]. The polar components (γsp) of H-free a-C were lower than that of a-C:H, while the 
dispersion components (γsd) of H-free a-C were higher than that of a-C:H, with the total 
surface free energy (γs) on H-free a-C and a-C:H having the same value. These results are 
due to differences in surface chemical composition, especially with regard to C-H bonds. 
C-H bonds are known as polar bonds, in contrast to C-C bonds. Therefore, since H-free 
a-C exhibited fewer C-H bonds and more C-C bonds than a-C:H, the polar components 
of H-free a-C were lower than that of a-C:H, and the dispersion components of H-free a-
C were higher than that of a-C:H. 
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Figure 4.1. Raman spectra of H-free a-C and a-C:H films. 
 
 
Figure 4.2. FT-IR spectra of H-free a-C and a-C:H films.  
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Table 4.1. Water contact angle, surface free energy, and zeta potential of H-free a-C and 
a-C:H films. 
 
 
 
 
4.3.2. Biocompatibility tests 
Figure 4.3 shows the average quantities of E. coli adhered to untreated PTFE, the 
PTFE coated with a-C:H, and the PTFE coated with H-free a-C. Figure 4.4 shows the 
representative images of colony adhesion to the surface of each sample. The average 
quantities of E. coli on the a-C:H and H-free a-C were each significantly lower than that 
on PTFE substrate. Moreover, the average quantities of E. coli on the H-free a-C was 
approximately one-twentieth of that on the a-C:H.  
Figure 4.5 shows the number of platelets per unit area adhering to the surfaces of the 
control and substrates coated with a-C:H and H free a-C after 60 min of incubation with 
PRP. The number of platelets adhering to a-C:H and H-free a-C was significantly lower 
when compared to that on the Control. In addition, the number of platelets adhering to H-
free a-C was approximately one-third of that on a-C:H. 
Figure 4.6 shows representative images of platelet adhesion to the surfaces of the 
control and substrates coated with a-C:H and H-free a-C by SEM. Platelets adhering to 
the control had become spread out and flattened owing to their activation, whereas on H 
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free a-C, a few platelets were attached; the morphology of such platelets was spherical 
and they had not become activated. The surface of a-C:H exhibited both platelets that had 
become flattened and spread out, as well as those that had remained spherical.  
On the basis of our results, H-free a-C was found to be a material with excellent 
antibacterial and antithrombogenic properties. We consider that the surface 
characterizations of carbon films affect cell activity. According to Zhou et al., the 
antibacterial properties of H-free a-C may result from its chemical inertness because of 
weakened chemical interaction in the bacteria adhesion process [4.7]. Moreover, it is said 
that the interactions between bacteria and its adhesion surface includes electrostatic and 
van der Waals forces [4.19]. In the components of surface free energy, the polar 
component (γsp) of H-free a-C was lower than that of a-C:H, while the dispersion 
component (γsd) of H-free a-C was higher than that of a-C:H (Table 4.1). Therefore, there 
is the possibility that difference of the polar components of a-C:H and H-free a-C affects 
the antibacterial properties.  
On the other hands, there have been several reports that platelet adhesion to 
amorphous carbon films is related to wettability. For example, more hydrophilic surfaces 
promote a greater affinity for platelet attachment and spreading than hydrophobic 
amorphous carbon [4.20]. In addition, the amorphous carbon family exhibits improved 
antithrombogenic properties with relatively hydrophobic surfaces compared with 
conventional amorphous carbon[4.21-25]. Therefore, we considered, as one potential 
factor, the possibility that hydrophobic H-free a-C suppressed the adhesion and activation 
of platelets. Moreover, surface free energy is also one factor in biomaterial-induced 
thrombosis[4.26]. In particular, the low surface free energy can result in the reduced 
adhesion of platelets[4.17]. In this study, however, there was no difference between the 
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surface free energies (γs) of H-free a-C and a-C:H; therefore, the surface free energies of 
H-free a-C and a-C:H cannot be related to suppress adhesion or activation of platelets. 
According to Park et al., the platelet adhesion of films increases owing to the increase in 
the of polar components [4.27]. Hence, H-free a-C suppressed thrombus formation owing 
to fewer polar components. Furthermore, Ma et al. proposed that since albumin 
adsorption increases with reduction in the hydrogen content of the a-C:H, the higher the 
ratio of albumin/fibrinogen adsorption on the film is, the more antithrombogenic the 
properties of the film improved [4.15], which may support our discussion. 
However, the adhesive behavior of bacteria and platelets on material is more complex 
and further investigation is needed to clarify factors which affects the complex behavior. 
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Figure 4.3. Average quantities of E. coli adhered to untreated PTFE, a-C:H, and H-free 
a-C. 
 
 
(a)              (b)              (c) 
Figure 4.4. Representative images of E. coli adhered to (a) untreated PTFE, (b) a-C:H, 
and (c) H-free a-C. 
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Figure 4.5. Number of platelets adhered to control (polycarbonate), a-C:H, and H-free 
a-C. 
 
 
(a)              (b)              (c) 
Figure 4.6. Representative SEM images of platelets adhered to (a) control 
(polycarbonate), (b) a-C:H, and (c) H-free a-C. 
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4.3.3. Characterizations of the plasma-treated PTFE and the interlayer 
Figure 4.7 shows the surface composition for each plasma treatment time on the 
PTFE substrates, as measured via XPS. The surface chemical composition of untreated 
PTFE consisted of about 30.9 at.% carbon and 69.1 at.% fluorine, and these figures were 
close to the theoretical values. Approximately 0.2 at.% oxygen was also detected, but the 
signal was too small for reliable deconvolution. The surface chemical composition of the 
a-C:H:F on PTFE consisted of about 43.1 at.% carbon, 1.8 at.% oxygen and 55.1 at.% 
fluorine.  
In O2 plasma treatment, the C1s spectrum was similar to that of untreated PTFE (Fig. 
4.8(a)). Moreover, there was no significant difference between the F/C ratio for untreated 
PTFE and that of the O2-plasma-treated PTFE. The study results of Ozeki and Hirakuri 
also showed no functional group was formed on the PTFE surface during O2 plasma 
treatment [4.11], which was consistent with the results of our study. In Ar plasma 
treatment, the concentration of fluorine decreased from 69.1 to 51.4 at.%, and the 
concentration of oxygen increased to 7.3 at.% after 300 s of exposure (Fig. 4.7(b)). The 
F/C ratio decreased immediately from 2.2 to 1.3 at.% with increasing the plasma 
treatment time. Moreover, the peaks of C-O and C=O bonds in C1s spectra increased and 
those of CF2 bonds decreased as Ar plasma treatment time increased (Fig. 4.8(b)). From 
the results, it can be stated that Ar plasma treatment caused the desorption of fluorine and 
the introduction of oxygen on PTFE. The introduction of oxygen on PTFE surfaces during 
nonoxygen plasma treatment is a common phenomenon [4.28, 29]. Free radicals that are 
created on a PTFE surface during treatment in Ar plasma can react with atmospheric 
oxygen [4.28]. 
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Figure 4.7. Chemical composition of PTFE surface after (a) O2 plasma and (b) Ar 
plasma treatments by XPS. 
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(a) 
 
(b) 
Figure 4.8. C1s spectra of PTFE surfaces after (a) O2 plasma and (b) Ar plasma 
treatments by XPS. 
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4.3.4. Adhesive tests 
The peel strengths of O2 (interlayer), O2 (no interlayer), and no pretreatment are 
shown in Fig. 4.9(a), and those of Ar (interlayer), Ar (no interlayer), and no pretreatment 
are shown in Fig. 4.9(b). The peel strengths of plasma-treated samples [O2 (interlayer) 
and O2 (no interlayer)] improved in comparison with no pretreatment (Figs. 4.9(a) and 
4.9(b)). 
The peel strengths of O2 (interlayer) and O2 (no interlayer) were independent of 
plasma treatment time. In comparing O2 (interlayer) and O2 (no interlayer), the peel 
strength of O2 (interlayer) was lower than that of O2 (no interlayer). With Ar plasma 
treatment, there was no difference in the peel strength of Ar (no interlayer) given different 
plasma treatment times. On the other hand, the peel strength of Ar (interlayer) increased 
proportionally with the plasma treatment time. When Ar (interlayer) and Ar (no 
interlayer) are compared, the peel strength of Ar (interlayer) can be seen to be lower that 
of Ar (no interlayer) at a treatment time of 30 s. However, the peel strength of Ar 
(interlayer) became higher than that of Ar (no interlayer) when plasma treatment took 
place during periods lasting over 60 s. 
The results indicated that the peel strength in cases involving PTFE and H-free a-C 
improved with plasma treatment. This can be explained by the removal of the weak 
boundary layer (WBL). Since the problem of adhesive properties on PTFE was caused 
by WBLs such as foreign matter, impurities, additives, and low-molecular-weight 
substances [4.30], the increase in adhesive strength was attributed to the cleaning of the 
PTFE surface by O2 or Ar plasma treatment. There was no change in peel strength with 
plasma treatment over time involving the O2 (interlayer), O2 (no interlayer) or Ar (no 
interlayer) surfaces. On the other hand, the peel strength of Ar (interlayer) increased with 
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plasma treatment time. These results could be related to the chemical composition of the 
PTFE surfaces. On the basis of Fig. 4.8(a), since it can be seen that the surface chemical 
composition of the O2-plasma-treated PTFE did not change, the peel strength of both O2 
(interlayer) and O2 (no interlayer) did not improve, regardless of plasma treatment time. 
Looking at Fig. 4.8(b), it can be seen that the desorption of fluorine occurred with Ar 
plasma treatment, and the surface chemical composition became similar to that of the a-
C:H:F interlayer. Consequently, the peel strength of Ar (interlayer) increased in 
proportion to plasma treatment time, whereas the peel strength of Ar (no interlayer) did 
not change with plasma treatment time. The peel strength of O2 (interlayer) was lower 
than that of O2 (no interlayer). The peel strength of Ar (interlayer) was also lower than 
that of Ar (no interlayer) with a treatment time of 30 s. The 300 s Ar-plasma-treated PTFE 
coated with the interlayer proved to have the strongest adhesive properties among the 
samples used in the T-peel test. 
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Figure 4.9. Peel strength between H-free a-C and PTFE with (a) O2 plasma treatments 
and (b) Ar plasma treatment via T-peel test. 
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4.4. Conclusions 
The bacterial adhesion tests indicated that the H-free a-C surface dramatically reduced 
bacterial adhesion in comparison with the surface of untreated PTFE and a-C:H. 
Furthermore, the numbers of adhesive platelets and activated platelets were the lowest on 
the H-free a-C surface, indicating that the surface was the most antithrombogenic among 
the samples. The surface of PTFE was improved in terms of adhesive properties via Ar 
plasma treatment and the introduction of the interlayer of a-C:H:F. These results indicated 
that the pretreated PTFE coated with H-free a-C is a promising candidate biomaterial for 
medical devices.  
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Chapter 5 
Fluorine Incorporated Hydrogen-free Amorphous Carbon 
Thin Film for Medical Implants 
 
5.1. Introduction 
   Advanced blood-contacting implant devices such as stents, artificial valves, or 
ventricular assist devices have become more effective in reducing the mortality rate 
associated with cardiovascular diseases. However, there remain serious concerns about 
the implantation of such devices, from both biological and mechanical aspects. Material-
related complications are obstacles to the use of such implants. Interactions between 
biomaterials and the human body can cause serious problems [5.1, 2]. In particular, 
devices that come into contact with human blood frequently induce biomaterial-
associated thrombosis [5.3].  
On the other hand, friction and wear that occur in parts of implant devices that move 
mechanically also pose risks [5.4]. Recently, much research has been pursued in the field 
of surface engineering with the aim of resolving the problems associated with the 
mechanical and biocompatible properties of bulk materials. Modification of surface 
properties, such as plasma-surface modification, is a crucially effective way to improve 
the interaction between human blood and implanted materials, and thus enhance the 
physical properties of these materials [5.5]. Surface coating is an interesting method for 
improving the mechanical and biocompatible properties of devices in direct contact with 
blood and tissue. In particular, the surface coating of amorphous carbon (a-C), which is 
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known as diamond-like carbon, has gathered much attention. The a-C coating has 
excellent properties such as wear resistance, hardness, chemical inertness, and 
biocompatibility [5.6]. Therefore, a-C is recognized as a biocompatible coating material 
and is commercially applied to medical implants, including stents and blood pumps for 
artificial hearts [5.7-9].  
   Previously, we studied fluorine-incorporated hydrogenated amorphous carbon (a-
C:H:F) which is amorphous carbon composed of carbon, hydrogen, and fluorine as a 
promising coating material because of its outstanding blood-compatible properties. We 
reported that doping fluorine into hydrogenated amorphous carbon (a-C:H) film 
contributes to the suppression of blood-cell adhesion, adsorption of plasma protein, and 
adhesion of inflammatory cells, and that a-C:H:F-coated metals can play the non-toxic 
mediating role in vivo [5.10-13]. Furthermore, we developed an a-C:H:F coating 
technique for vascular interventional devices by the radiofrequency-plasma-enhanced 
chemical vapor deposition (RF-PECVD) method [5.14].  
   However, the mechanical strength of a-C:H:F films is too low for them to be applied 
to mechanical medical devices such as blood pumps of ventricular assist devices or 
artificial heart valves. This is because fluorine incorporation results in the formation of 
C-Fx bonds, which change the diamond-like carbon structure into a polymer-like 
structure, thus reducing the film hardness [5.15]. The hardness of fluorine-incorporated 
a-C coatings must be increased for broader applications. In this regard, we focused on the 
carbon structure of hydrogen-free tetrahedral amorphous carbon (ta-C) in order to 
synthesize hard fluorine-incorporated a-C coatings, because ta-C consists of sp3-rich 
carbon structure including no hydrogen and shows excellent mechanical properties [5.16]. 
Therefore, we propose the synthesis of fluorine-incorporated hydrogen-free amorphous 
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carbon (a-C:F), focusing on both the blood compatibility of a-C:H:F and the excellent 
mechanical properties of ta-C. In this study, we prepared the a-C:F films by the vacuum 
arc deposition method and evaluated the influence of fluorine doping on ta-C and the 
blood-compatible properties of a-C:F films.  
  
Chapter 5 
 103 
5.2. Experimental details 
5.2.1. Preparation of a-C film  
   In this study, we synthesized ta-C, a-C:F, and a-C:H:F films on silicon wafers and 
super-hard alloy (tungsten carbide (Wolframcarbid-Cobalt (WC-Co)) substrates. The ta-
C and a-C:F films were deposited by the filtered cathodic vacuum arc (FCVA) method 
(YH-100NX, Onward Giken Co., Ltd., Japan) to generate clean carbon ion plasma in 
which the droplets were removed. We used a graphite target (DFP-2, Poco Graphite, Inc., 
TX, USA) as the cathode material, which is the source material of films, and introduced 
perfluoropropane gas (C3F8: Iwatani Corp., Japan) into the vacuum chamber for doping 
fluorine into ta-C films. We synthesized three types of a-C:F films whose fluorine 
contents were controlled by varying flow rates of C3F8 gas (10, 30, and 50 sccm). The 
deposition was carried out by an arc voltage and arc current of 15 V and 40 A, respectively. 
The back pressure of the apparatus was about 1.0 × 10−3 Pa, and the DC negative bias of 
substrates was fixed to −100 V on the basis of the previously reported substrate bias 
voltage, which is the condition in which the hardest ta-C is synthesized [5.16]. Fluorine-
incorporated hydrogenated amorphous carbon (a-C:H:F) was synthesized as a control 
material with RF-PECVD equipment (YH-100NX, Onward Giken Co., Ltd., Japan) on 
the basis of our previous study [5.17]. The a-C:H:F film deposition was performed using 
a mixture of acetylene (C2H2: Koatsu Gas Kogyo Co., Ltd., Japan) and C3F8 gas. The 
flow rates of C2H2 and C3F8 were 5 sccm and 50 sccm, respectively. 
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5.2.2. Characterization of a-C films 
5.2.2.1. Chemical composition and bonding state 
   Chemical compositions and bonding states of the a-C film surfaces were measured by 
X-ray photoelectron spectroscopy (XPS: JPS-9010TR, JEOL Ltd., Japan). The X-ray 
photoelectron of C1s, F1s, and O1s spectra were measured using an Mg-Kα source (10 
mA, 10 kV). After measuring the spectra of the film surface, the interiors of samples 
exposed by Ar sputtering were also measured. The carbon, fluorine, and oxygen 
concentrations of the film surface and interior were calculated from each peak area and 
corresponding relative sensitivity factors for each sample.  
5.2.2.2. Carbon microstructure 
   The carbon microstructure of the a-C films was investigated using a Raman 
spectrometer (inVia, Renishaw plc., UK). Raman spectroscopy was performed at room 
temperature using the 532-nm line from the Ar laser, and the spectra of each sample were 
recorded from 1100 to 2100 cm−1. After measuring the spectra, the background was 
subtracted, and the spectra were fitted by two Gaussian peaks to determine the peak 
positions. 
5.2.2.3. Wettability 
   The wettability of each a-C film was evaluated by measuring the static contact angles 
between a droplet (2.0 µl) of distilled water and the sample surface at room temperature. 
The value of the water contact angle is the average of 10 samples. Contact angle 
measurements were conducted using a sessile drop method with DM 500 (Kyowa 
Interface Science Co., Ltd.). 
5.2.2.4. Blood-compatible properties  
   In this study, protein adsorption and platelet adhesion tests were used for evaluating 
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the blood compatibility of the a-C film. Plasma protein adsorption tests were performed 
by treating the a-C samples with bovine serum albumin and fibrinogen (Sigma-Aldrich, 
St. Louis, MO, USA) solutions and measuring the absorbance through bicinchoninic acid 
(BCA) assay analysis. Each protein was dissolved separately in phosphate buffered saline 
(PBS, pH 7.4) at concentrations of albumin and fibrinogen adjusted to 30 and 3 mg/mL, 
respectively. The three deferent samples, which were rinsed with PBS beforehand, were 
incubated with 1.0 mL of each protein solution in 24 wells at 37 °C for 60 min in an 
atmosphere of 5% CO2. After incubation, each sample was moved into a new group of 24 
wells to avoid contamination with proteins adsorbed on the surface of the wells used for 
incubation and carefully washed three times with PBS to completely remove unabsorbed 
proteins on samples. The washed samples were incubated with 250 µl of 1% sodium 
dodecyl sulfate in PBS at room temperature for 60 min by shaking. The 150 µl of resultant 
solutions were extracted into 96 wells along with 150 µl of BCA working solution (Micro 
BCA Protein Assay Kit, Thermo Fisher Scientific Inc., USA) and incubated at 37 °C for 
120 min in an atmosphere of 5% CO2. The absorbance of each well was measured at 562 
nm using a microplate reader (SH-1200, CORONA ELECTRIC Co., Ltd., Japan), and the 
adsorbed protein concentrations were calculated using calibration curves. After 
measuring each protein concentration, we calculated the albumin/fibrinogen ratio.   
   The anti-thrombogenic property of each sample was evaluated by the platelet-covered 
area on samples after the platelet adhesion test. In this study, human whole blood (85 mL) 
was collected from healthy volunteers who had not taken any medication for at least 10 
days. After mixing the blood with 15 mL of acid-citrate-dextrose, platelet-rich plasma 
(PRP) was isolated by centrifugation at 1500 rpm and 20 °C for 15 min. Supernatant 
blood plasma was collected as PRP, and subsequently, the remaining blood was 
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centrifuged at 1000 × g and 4 °C for 10 min to obtain platelet-poor plasma (PPP). The 
density of platelets in PRP was adjusted to about 3.0 × 105 cells/µl by dilution with PPP. 
After rinsing Si substrates coated with a-C with PBS, samples were incubated in 24 wells 
containing 1.0 mL of adjusted PRP at 37 °C for 30 min in an atmosphere containing 5% 
CO2 gas. Thereafter, PRP was removed from each well, and the samples were washed 
with PBS. Adherent platelets on samples were then fixed for 2 h at room temperature in 
0.8 mL of freshly prepared 1.0% glutaraldehyde in PBS. After fixation, the samples were 
washed and dehydrated in a graded ethanol series (20%, 40%, 60%, 80%, 90%, 100%, 
and 100% for 10 min each). The dehydrated samples were observed via differential 
interference contrast microscopy (BX63, OLYMPUS Co., Japan). The area covered by 
adherent platelets were manually measured on photographs of samples (n = 10, 10800 
µm2) using imaging software (cellSens, OLYMPUS Co., Japan). 
5.2.2.5. Hardness 
   The hardness of the films was measured by a nanomechanical tester (Nano Indenter 
G200, KLA-Tencor Corp., CA, USA) with a Berkovich diamond indenter. To measure 
the hardness, ta-C, a-C:F10, a-C:F30, and a-C:H:F films, which had 500 nm of thickness 
on WC-Co substrates, were prepared. Indentation load and depth are 1.0 mN and 
approximately 100 nm, respectively. A total of 10 different surface points were tested, 
and the load-displacement curve was analyzed using the Oliver and Pharr method [5.18]. 
The hardness of a-C:F50 film was not measured, because it was not possible to synthesize 
a sufficiently thick film.   
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5.2.3. Statistical analysis 
   SPSS software (SPSS 24.0, IBM Co., U.S.A.) was used for the statistical analysis. 
The results are expressed as the mean values with the corresponding standard deviation. 
For statistical analysis of the platelet-covered area, quantitative variables were compared 
using one-way ANOVA with post-hoc Tukey test. The differences were considered 
statistically significant when the p-value was less than 0.05. 
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5.3. Results  
5.3.1. Chemical bonding and composition 
   Figure 5.1 shows the surficial and interior chemical composition of carbon, fluorine, 
and oxygen measured by XPS. Fluorine on a-C:F film surface increased with the flow 
ratio of C3F8 gas, increasing from about 10 to 50 at.% (Figure 5.1(a)). In particular, the 
fluorine content ratio of a-C:F50 was much higher than that of a-C:H:F. On the other hand, 
when the flow rate of the gas changed from 30 to 50 sccm, the fluorine content ratio of a-
C:F film (about 30 at.%) did not increase (Figure 5.1(b)).  
 
Figure 5.1. Chemical composition of a-C film (a) topmost surface and (b) surface after 
Ar-sputtering by XPS.  
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   The local spectra of C1s for a-C film by XPS are shown in Figure 5.2. The horizontal 
axis corresponds to the binding energy (eV), and the vertical axis corresponds to the 
intensity. Figure 5.2(a) shows the chemical bonding states of the a-C film topmost surface. 
This result shows an increase in the C-CF (287 eV), C-F (289 eV), and C-F2 (292 eV) 
bond spectra on the topmost surfaces of a-C:F film, as the C3F8 flow rate increases during 
deposition. However, the spectra of the interior hardly changed by increasing the C3F8 
gas in a-C:F30 and a-C:F50. 
 
 
 
Figure 5.2. C1s XPS spectra for a-C film (a) topmost surface and (b) surface after Ar-
sputtering.  
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   With the FCVA method, in this study, we synthesized a-C:F film, whose fluorine 
content ratio was controlled by varying the fluorocarbon gas pressure in the deposition 
process. From all results of XPS, it was revealed that the introduction of fluorocarbon 
gases during the FCVA method contributed to the introduction of fluorine into ta-C film, 
following the increase in C-Fx bonds. Fluorine concentrations of both the a-C:F30 film 
surface and interior were equal to that of a-C:H:F film. 
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5.3.2. Carbon microstructure 
   Raman spectra of the a-C films are shown in Figure 5.3. The a-C:F10 and a-C:F30 
films show the typical Raman spectra of diamond-like a-C films, which generally exhibit 
a G-band (1580 cm−1) and D-band (1350 cm−1), as reported by Robertson et al. [5.19], 
and in particular, the spectra of a-C:F10 and a-C:F30 is similar to ta-C. However, the G-
band peak position of a-C:F10 (1562 cm−1) and a-C:F30 (1545 cm−1) shifted to a lower 
wavenumber than ta-C (1574 cm−1), and the spectrum of a-C:F30 sloped slightly 
compared with ta-C and a-C:F10. On the other hand, the spectrum of a-C:F50 is similar 
to that of a-C:H:F, which is a linear and inclined spectrum, typical of polymer-like a-C 
films.  
 
Figure 5.3. Raman spectra of a-C films.  
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5.3.3. Water contact angle  
   The water contact angles are shown in Figure 5.4. As the fluorine concentration 
increased on the a-C:F surface, the water contact angle increased: ta-C (76.7° ± 1.1°), a-
C:F10 (80.3° ± 1.1°), a-C:F30 (87.5° ± 1.3°), a-C:F50 (95.0° ± 1.4°), and a-C:H:F (91.8 
± 1.6°). The a-C:F50 coating exhibited a much higher water contact angle than a-C:H:F 
coating. 
 
 
 
 
 
Figure 5.4. Water contact angle for each a-C film surface. 
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5.3.4. Biocompatibility 
   The amount of albumin and fibrinogen adsorbed onto the a-C samples were measured 
using a micro-BCA assay, and the ratio of albumin to fibrinogen adsorption was 
calculated (Figure 5.5). A higher ratio of albumin to fibrinogen adsorption was observed 
on samples coated with a-C:F film, compared to ta-C film. Furthermore, as the fluorine 
concentration increased, the albumin/fibrinogen ratio also increased.  
 
 
 
 
 
Figure 5.5. Albumin/fibrinogen ratio for each a-C film. 
  
Chapter 5 
 114 
   Figure 5.6 shows the percentage of platelet-covered area on each sample after the 
platelet adhesion tests. The covered area on a-C:F samples is significantly lower than that 
for ta-C coated samples (p values are listed above bars). Furthermore, the a-C:F30- and 
a-C:F50-coated samples suppressed the platelet-covered area in the same degree as the 
blood-compatible a-C:H:F coating and statically there are no significant differences 
between these three samples (p < 0.05).  
 
 
 
 
Figure 5.6. The percentage of human platelets covering area on each a-C film per 
observed unit area. p-values are listed above bars. 
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5.3.5. Hardness 
   Figure 5.7 shows the hardness of a-C films on WC-Co substrates measured using a 
nano-indentation tester. Although the hardness of a-C:F10 (22.7 GPa) and a-C:F30 (8.3 
GPa) films are much lower than the hardness of ta-C film (75.2 GPa), those films are 
much harder than a-C:H:F film (0.7 GPa). It was shown that a-C:F30 not only has blood 
compatibility equal to that of a-C:H:F but also hardness of more than 10 times that of a-
C:H:F. 
 
 
 
 
 
Figure 5.7. The hardness of each a-C film. 
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5.4. Discussion 
5.4.1. Chemical structure of a-C:F 
   In this study, the film structure was evaluated, as the chemical composition was 
measured by XPS, and the carbon microstructure was observed with Raman spectroscopy. 
The results of XPS showed that the increase in fluorocarbon gas flow rate related to an 
increase in both the fluorine content in the film surfaces and in the film interiors, although 
the fluorine content ratios on the interiors were lower than those on the surfaces (Figure 
5.1). Furthermore, it was indicated that the increase in fluorine concentration resulted 
from the presence of C-Fx bonds due to the introduction of fluorocarbon gas into the 
deposition process (Figure 5.2). These results mean that the fluorocarbon gas flow rate 
was an effective factor in synthesizing highly fluorine-incorporated a-C:F coating by the 
FCVA method, in which the same degree of arc voltage, arc current, and bias voltage as 
the current study is used. The results of Raman spectroscopy also showed that the 
fluorocarbon gas flow rate affected the carbon nanostructure of a-C:F (Figure 5.3). It was 
shown that a-C:F10 and a-C:F30 had a diamond-like carbon network structure, like ta-C, 
whereas a-C:F50 had a polymer-like carbon structure, like a-C:H:F. Previous studies 
showed that ta-C, which has many sp3 bonds, exhibits a small D-band peak [5.16, 20], 
and ta-C film also shows a Raman spectrum with a small D-band peak in this study. The 
spectra of a-C:F10 and a-C:F30 films imply that they have a more vulnerable carbon 
network than ta-C, because they exhibit a lower G-band peak position, which indicates 
more disordered sp2 bonds than ta-C film, and in particular, a-C:F30 has a slightly 
luminescent background. Moreover, introducing much more fluorine into a-C:F films, i.e. 
a-C:F50, caused the background of Raman spectra to be greatly inclined, like a-C:H:F 
film. The inclined background of a-C film indicated photoluminescence due to the 
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polymeric carbon structure [5.21], and this phenomenon has been found when fluorine 
was incorporated in a-C coating [5.22]. This tendency is also observed in the spectrum of 
a-C:F30, which is slightly inclined compared with ta-C and a-C:F10. Consequently, these 
results showed that the introduction of fluorocarbon gas contributed to the increase in C-
Fx bonds and the polymer-like carbon network structure.  
   It is considered that these contributions are related to the increase in fluorocarbon ions 
and the loss of carbon ion energy, due to the increase in the collisions between carbon 
ions and fluorocarbon gases, in proportion to the flow rate of fluorocarbon gas during the 
FCVA deposition process. The introduction of additional C-Fx bonds and the increase in 
the fluorine content of a-C:F film (Figure 5.1, 2) are considered to have been induced 
simply by the increase in fluorocarbon ions. On the other hand, changes in the carbon 
network in a-C:F (Figure 5.3) seems to have been caused by both the increase in 
fluorocarbon ions and the loss of carbon ion energy. In general, the presence of fluorine 
influences the connectivity of the carbon network in a-C film as fluorine terminates the 
carbon network [5.22]. Moreover, carbon ion energy is also an important factor to form 
diamond-like structure including rich sp3 C–C bonds: the sp3 content fraction increases 
with carbon ion energy even though it has a threshold value [5.19]. In previous studies, 
ta-C was deposited at approximately −100 V of bias voltage when using the FCVA 
method, inducing much of the sp3 fraction into the ta-C film and making it hard enough 
[5.16, 23]. In this study, therefore, the bias voltage was optimized and fixed to −100 V. 
However, the carbon ion plasma generated by arc discharge is used not only for the 
formation of the carbon structure as the precursor but also the decomposition of 
fluorocarbon gas when synthesizing a-C:F. Therefore, a sufficient tetrahedral carbon 
network could not be formed because of the consumption of carbon ion energy for 
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decomposition, and this would cause the increase in high fluorine concentration in a-C:F. 
This description would explain that the Raman spectra of a-C:F30 and a-C:F50 films 
significantly differed, whereas the bonding states in their interiors shown by XPS C1s 
spectra are quite similar. 
 
5.4.2. Blood compatibility 
   In this study, blood compatibility was evaluated by protein adsorption and platelet 
adhesion tests. In the protein adsorption test, the amounts of albumin and fibrinogen 
adsorbed on the a-C film were measured because the ratio of albumin to fibrinogen is 
reportedly a useful indicator for assessing the blood compatibility of a biomaterial [5.24]. 
Albumin is the major constituent of blood plasma, and many previous studies have 
reported that the adsorption of albumin passivates biomaterial surfaces, reducing both 
inflammatory and thrombogenic responses [5.25, 26]. Fibrinogen is a key protein in the 
blood coagulation cascade and enhances the adhesion and activation of platelets. 
Fibrinogen supports platelet adhesion and aggregation through its binding to the platelet 
membrane glycoprotein GPIIb/IIIa, and its conformational changes induced by surface 
chemistry are crucial for this interaction [5.27]. It was considered that a higher ratio of 
albumin/fibrinogen corresponds to a lower number of adherent platelets on the sample 
surfaces. The a-C:F film exhibited a higher albumin to fibrinogen ratio than the ta-C film 
(Figure 5.5), which may be related to the low number of adhering platelets. In particular, 
a-C:F30 and a-C:F50 films for which the albumin/fibrinogen ratio increased showed a 
low tendency to induce thrombus formation, equivalent to a-C:H:F film.  
   Our research group previously studied the characteristics of a-C:H:F and the 
relationship to blood compatibility, and we reported that C-Fx bonds on the topmost 
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surface of a-C:H:F film with higher fluorine concentration made the surface free energy 
lower and the contact angle higher, resulting in the increase in the albumin/fibrinogen 
ratio and the suppression of platelet adhesion on a-C:H:F [5.11]. In this study, the fluorine 
content ratio on the membrane surface was larger, on the order of the C3F8 flow rate 
(Figure 5.1(a)), and a-C:F30 and a-C:F50 have shown a greater amount of fluorine 
induced by C-Fx bonds than a-C:H:F (Figure 5.2(a)). Furthermore, the a-C:F film surface 
exhibited hydrophobicity as the fluorine content ratio increased (Figure 5.4). Therefore, 
it is considered that the blood compatibility of a-C:F films resulted from hydrophobicity 
caused by introduction of C-Fx bonds on their surfaces.  
 
5.4.3. Hardness 
   In this study, we deposited ta-C and a-C:F films by filtered arc deposition (FAD), 
using the FCVA method. The nano-indentation hardness of ta-C is 75.2 GPa, as previous 
studies reported that the nano-indentation hardness of ta-C deposited by FAD is 70–80 
GPa [5.16]. In this study, the hardness of ta-C declined to 8.3 GPa by introducing 30 sccm 
of fluorocarbon gas into the deposition process. It is considered that changes in the carbon 
network led to the decline in the hardness of a-C films because the hardness of a-C films 
depends on the ratio of sp3 C-C bonds [5.28]. The carbon nanostructure evaluated by 
Raman spectra suggested that by fluorocarbon introduction, the carbon structure of ta-C 
gradually shifted from a diamond-like tetrahedral structure to a polymer-like structure, as 
shown by the shift in the G-band peak and the slope of the spectra. Several papers have 
reported that the hardness of a-C:F film decreases as more fluorine is incorporated [5.15, 
29], because the connectivity of the carbon network is reduced by C-F bonds, consisting 
of terminal bonds, and the loss of the source ion. However, the hardness of a-C:F30, 
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which has as much fluorine content ratio as a-C:H:F, is ten times higher than that of a-
C:H:F in spite of the equivalence of C-F bonding states. The a-C:F30 film clearly 
maintains its carbon nanostructure as diamond-like, whereas a-C:H:F exhibits a polymer-
like carbon network. This shows that the introduction of fluorocarbon gas during the 
FCVA deposition process of ta-C is effective in synthesizing blood-compatible and hard 
fluorine-incorporated a-C film because it is possible to compose a diamond-like carbon 
nanostructure with the FCVA method. 
  
Chapter 5 
 121 
5.5. Conclusions 
Fluorine-incorporated hydrogen-free amorphous carbon (a-C:F), which was deposited 
using the FCVA method, showed much more anti-thrombogenic properties than ta-C. 
Furthermore, the anti-thrombogenic properties of a-C:F, which was synthesized under a 
strong fluorocarbon atmosphere, were equivalent to the a-C:H:F coating, which has 
already been recognized as an anti-thrombotic coating. On the other hand, a-C:F was also 
much harder than the a-C:H:F coating, even when the fluorine content ratio of a-C:F was 
equal to that of a-C:H:F. Therefore, a-C:F synthesized with the FCVA method exhibited 
both blood compatibility and hardness, and showed suitable properties as a coating for 
machine parts of blood-contacting medical devices. 
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Chapter 6 
Technique for preparing cross sections of platelets and 
fluorinated diamond-like carbon coatings on substrates for 
transmission electron microscopy analysis 
 
6.1. Introduction 
   Thrombus formation on the surfaces of medical devices that contact blood is a serious 
problem, with platelet adhesion being a key event in thrombus development during blood-
material interactions. Consequently, it is necessary to improve the biocompatibility and 
hemocompatibility of biomaterials to reduce the risk of platelet 
aggregation/thromboembolism and complications during extended anticoagulant 
administration. Since platelets are highly adhesive and interact with biological and 
artificial surfaces through a number of mechanisms, the reduction of platelet adhesion 
and activation is fundamental for the successful application of a biomaterial. 
   In order to control platelet adhesion, surface modification techniques for enhancing 
the anti-adhesion/anti-activation of platelets have been reported and primarily focus on 
the chemical modification of implant surfaces [6.1, 2]. Fluorinated hydrogenated 
amorphous carbon (a-C:H:F) has particularly received considerable attention recently due 
to properties such as chemical inertness [6.3], low surface energy [6.4], increased 
hydrophobic properties [6.5]. As described in chapter 1, our group previously reported 
that a-C:H:F markedly inhibits platelet adhesion and activation in human blood [6.6, 7]. 
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The physiological mechanism may also rely on the platelet response being dependent on 
implant surface topographical features such as roughness and hierarchical structure [6.8, 
9]. Ding et al. reported that microtopographic grooves and pillar patterns could 
manipulate platelet adhesion and activation [6.10]. However, the relationship between 
surface morphology/chemistry and the physiological mechanism by which “one platelet” 
is involved in the initial thrombotic event remains poorly understood. Consequently, 
investigations of the interactions between single platelets and the surfaces of biomaterials 
are required to overcome thrombogenic problems. 
   Ultrastructural analysis of a single platelet on a biomaterial surface using transmission 
electron microscopy (TEM) is technically more difficult than light or scanning electron 
microscopy (SEM) analysis, but it is useful for attaining a deeper understanding of 
coagulation mechanisms in physiology. Yoshimoto et al. reported TEM methods for 
observing the internal structures and adhesion interfaces of single human platelets 
attached to medical grade polycarbonate (PC) and a-C:H surfaces and showed cross-
sectional images of single human platelets on PC surfaces [6.11]. However, cross-
sectional images of a single human platelet on a-C:H were compromised due to coating 
cracks at the interface. Moreover, no observations of a single platelet on grooved surfaces 
have been reported.  
   The aim of this study was to obtain cross-sectional images of single platelets on the 
hydrogenated amorphous carbon family, especially a-C:H:F. We report improved 
procedures for embedding and ultrathin sectioning of biomaterials for TEM observation 
that preserve the platelet/carbon coating/substrate interface. Furthermore, we show 
images of single platelets on a physically and chemically surface-modified biomaterial, 
a-C:H:F-coated groove-patterned PC.  
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6.2. Materials and Methods 
   Before observing platelets on samples, we first analyzed the materials used in this 
study. Thereafter, the slice direction (vertical, oblique, and horizontal) with a diamond 
knife was optimized for preparing TEM samples without wrinkles, followed by 
observations of surface-induced platelet activation on a-C:H:F samples. Finally, we 
conducted cross-sectional observation of platelets on a-C:H:F coated flat and groove-
patterned PC with the improved procedure. 
 
6.2.1. PC substrate preparation 
   In this study, flat and groove-patterned polycarbonate (PC: eupilon, MITSUBISHI 
GAS CHEMICAL COMPANY, INC., Tokyo, Japan) sheets were used as a substrate 
material of a-C:H:F film. The groove patterns were fabricated by a molding method using 
a grooved SiO2 master on a Si wafer. The master was fabricated by photolithography and 
a dry etching process. A silicon wafer with a thermally-oxidized 2-µm-thick layer was 
first coated with a negative resist (ZPN1150, Zeon Corp., Tokyo, Japan). Parallel channels 
of equal-sized grooves and ridges approximately 2 µm wide were then created on the 
resist-coated wafer with a mask aligner (SUSS MA6 BSA, SUSS MicroTec SE, Garching, 
Germany). The unmasked region of the SiO2 film (the developed region) was dry-etched 
(MUC-21, RV-APS-SE, Sumitomo Precision Products Co. Ltd., Hyogo, Japan) to a depth 
of 500 nm. The resist mask was then removed using N-methyl-2-pyrrolidone (NMP), 
acetone, isopropyl alcohol (IPA), and distilled water, followed by an oxygen plasma 
etching process to remove the resist completely. The size of the surface grooves was 
selected to approximate the size of platelets.  
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6.2.2. a-C:H:F film preparation 
a-C:H:F film was deposited on flat and groove-patterned PC substrates using a radio 
frequency (RF) plasma enhanced chemical vapor deposition (CVD) method from 
acetylene (C2H2) gas a mixture of hexafluoroethane (C2F6) and acetylene (C2H2) as the 
process gases. The RF (13.56 MHz) power and total pressure were fixed at 200 W and 
13.3 Pa, respectively[6.6]. Each a-C:H:F film was approximately 50 nm thick, although 
a-C:H:F films 500 nm thick were prepared on flat PC substrates to measure the hardness 
of them. 
 
6.2.3. Embedding resin preparation 
The embedding resin was prepared to observe cross-sectional images of platelets on 
a-C:H:F samples with TEM. As shown in Table 6.1, the Araldite-Epon resin (12 g: 
Araldite CY212, 12 g: Epon 812, 24 g: DDSA and 0.8 mL: DMP-30 (TAAB Laboratories 
Equipment, Ltd., Berkshire, UK)) was used in this study. Araldite-Epon resin was 
developed by Mollenhauer for embedding plant tissue [6.12]. Araldites shrink very little 
after polymerization and adhere with high affinity to hard materials due to their viscosity 
[6.13]. In our case, samples for TEM observation were prepared using a mixture of 
Araldite-Epon resin, because the sample includes resins, polymer substrates, platelets, 
and a-C:H family materials which is an inorganic material generally harder than organic 
polymer materials. 
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Table 6.1. Experimental Protocol. 
 
 
6.2.4. Sample analysis 
   The widths of hills and valleys of groove-patterned a-C:H:F samples were measured 
from surface images of three different samples. The surface chemical compositions of a-
C:H:F films on flat and groove-patterned PC were measured by XPS (JPS-9010TR, JEOL 
Ltd., Japan). The X-ray photoelectron of C1s and F1s spectra were measured using Mg 
Ka source (10 mA, 10kV). The concentration of carbon and fluorine on the a-C:H:F 
surface was calculated from each peak area and corresponding relative sensitivity factors, 
and then F/C ratio was calculated. The water contact angle measurements of droplets of 
distilled water (2 µl each) were conducted using the sessile drop method with a contact 
angle meter (DM 500, Kyowa Interface Science Co., Ltd., Japan) at five different points 
on each sample surface. The hardness of the a-C:H:F film, PC substrate, and Araldite-
Epon resin was measured by dynamic ultra micro hardness tester (DUH-211S, Shimadzu 
Scientific Instruments., Kyoto, Japan).   
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6.2.5. Optimization of observing cross-sectional images of a-C:H:F-coated PC 
substrates 
Cross-sectional images of a-C:H:F-coated flat PC were observed with TEM (JEM-
100C, JEOL Ltd., Tokyo, Japan). After embedding samples in Araldite-Epon resin, semi-
thin sections (0.5-1.0 µm) were cut using a Diatome diamond knife (Diatome, Biel, 
Switzerland), then stained with toluidine blue to select areas of interest for electron 
microscopy investigation. Ultrathin sections of the samples (approximately 80 nm) were 
cut in the vertical, oblique, and horizontal slice directions using a Diatome diamond knife 
to optimize image quality (Figure 6.1). Each direction is represented by an angle between 
the interface of the sample and the blade of the knife. Thereafter, the observation was 
performed with TEM using an acceleration voltage of 120 kV 
 
Figure 6.1. Schematic image of slicing directions used to prepare sections for TEM 
observation.  
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6.2.6. Observation of platelets on each sample 
   Whole blood was drawn from healthy volunteers who had not ingested aspirin or other 
medications that could interfere with platelet adhesion in the previous 10 days. The blood 
sample (44 mL) was mixed with 6 mL of acid-citrate-dextrose to prevent aggregation. 
Platelet-rich plasma (PRP) was obtained by centrifuging the whole blood at 360 ×g for 
15 min at room temperature. After centrifuging the whole blood, supernatant plasma was 
collected as PRP, and subsequently, the rest of the whole blood was centrifuged at 1000 
×g for 10 min to obtain platelet-poor plasma (PPP). The concentration of platelets in PRP 
was adjusted to 3.0 × 105 cells/µL by diluting with PPP. The flat and groove-patterned a-
C:H:F samples were washed with phosphate-buffered saline (PBS) three times, then the 
samples were incubated in a 24-well plate with 1 mL of 3.0 × 105 cells/µL platelets for 
60 min with 5% CO2 gas at 37°C. Thereafter, the supernatant was discarded and the 
samples were washed with PBS. Adhering platelets were fixed with 2.5% glutaraldehyde 
for 60 min at room temperature. The samples were rinsed with PBS three times and the 
platelets were post-fixed in 1% osmium tetroxide solution in PBS for 90 min at 4°C. And 
then each sample was dehydrated using an ethanol series at 4°C: 15 minutes in 50%, 70%, 
90%, then at room temperature: 15 minutes in 100%, 100%, 100% ethanol. After platelet 
adhesion test, sample surfaces were observed by SEM (Inspect S50, FEI, OR, US). Then 
platelets adhering onto the surfaces observation was performed in the same way as 
described in section 2.5.  
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6.3. Results 
6.3.1. Properties of each material 
   Table 6.2 shows each property of a-C:H:F-coated flat and groove-patterned PC 
substrates. Although they showed equal F/C ratio, the water contact angles of groove-
patterned a-C:H:F were higher than flat a-C:H:F samples. The hardness of a-C:H:F, PC, 
and Araldite-Epon was shown in Figure 6.2. The Araldite-Epon resin (150.4 ± 11.5 MPa) 
was harder than pure Epon resin (83.6   1.8 MPa), and there was no difference in the 
hardness between PC substrates (163.9 ± 4.2 MPa) and Araldite-Epon resin according to 
t test (p > 0.05). The hardness of a-C:H:F film (611.0 ± 50.8 MPa) was higher than the 
substrates and the embedding resin. 
 
Table 6.2. Properties of a-C:H:F-coated PC samples. 
Sample 
Width (µm):  
hills  
Width (µm):  
valleys  
F/C ratio (–) Contact angle (°) 
a-C:H:F-coated flat PC – – 0.63  95.1 ± 1.1 
a-C:H:F-coated groove-
patterned PC 
2.38 ± 0.05 1.57 ± 0.02 0.64  110.7 ± 2.9 
 
 
 
Figure 6.2. The hardness of a-C:H:F film, PC substrate, and Araldite-Epon resin.   
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6.3.2. Observation of Cross-sections of a-C:H:F Surfaces 
Figure 6.3 shows cross-sectional images of flat a-C:H:F surfaces observed with TEM. 
Throughout this article, bottom cross-sectional images show PC substrates and the top 
images show samples embedded in resin. We observed ordered wave-like wrinkles at the 
interface of the a-C:H:F films (marked by white arrows) and shadows (enclosed by white 
dots), when the samples were sliced in the vertical and oblique directions (Figure 
6.3(a),(b)). Horizontal slicing resulted in no waves in the a-C:H:F layer (Figure 6.3(c)). 
 
 
 
Figure 6.3. Cross-sectional TEM images of a-C:H:F coating on PC substrate: a) 
vertical, b) oblique, and c) horizontal slicing direction. Scale bar indicates 1 µm. The a-
C:H:F coating (between resin and substrate interface) is marked by black arrows. The 
dashed circles indicate wrinkles and shadows formed on samples. 
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6.3.3. Observation of Platelets Adhering onto a-C:H:F Surfaces 
   The SEM images of platelets on a-C:H:F-coated PC are shown in Figure 6.4. Figure 
6.4(a) shows that platelets on flat a-C:H:F were hardly activated and generally kept the 
spherical shape. On the other hands, Figure 6.4(b) shows some platelets on groove-
patterned a-C:H:F were activated and attached to hills and formed bridges between hills 
of the grooved pattern.  
 
 
 
 
Figure 6.4. Surface SEM images of a-C:H:F-coated PC substrate: (a) flat substrate (b) 
grooved-patterned substrate.  
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   Figure 6.5 shows cross-sectional images of surface-adhering platelets on the flat a-
C:H:F surface. Figure 6.5 likely shows the early stage adhesion of a platelet because the 
platelet is slightly spherical and the cytoplasm contains platelet-specific storage granules 
(dark spots in Figure 6.5; alpha granules and dense granules). Several bright spots in the 
platelets are the open canalicular system (OCS), a tubular system linking the interior of 
the platelet to the exterior. We observed these organelles and pseudopodia (protrusions 
that develop as the activation level of the platelet increases) in the image. Platelets 
attached to a-C:H:F films in the early stage of adhesion and activation show apical 
pseudopodia interacting with the surface.  
 
 
 
 
 
Figure 6.5. Cross-sectional images of a platelet in the early adhesion and activation 
stages on an a-C:H:F coating (indicated by a black arrow) following slicing in the 
horizontal direction.  
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   Figure 6.6 shows cross-sectional TEM images of platelets adhering onto groove-
patterned a-C:H:F surfaces. The a-C:H:F films in Figure 6.6 appear as dense uniform 
lines lying on the groove-patterned surface and follow the grooved surface which has no 
cracks or wrinkles. Platelets adhering onto the groove-patterned surface are either in the 
process of spreading or in a fully spread state, indicative of the highest level of platelet 
activation. Figure 6.4(a) shows tighter adhesion between the platelet and the groove-
patterned a-C:H:F surface at the hill part of the grooved pattern, with the platelets 
extending their pseudopodia to the valley part of the grooved surface. Figure 6.6(b) 
shows a platelet bridging the space between two grooves, with pseudopodia developing 
from the platelet bottom toward the surface grooved valley space (white arrows in Figure 
6.6(b)). Granules in organelles are located in the center of the platelet some distance from 
the platelet membrane.  
 
 
 
Figure 6.6. A cross-sectional TEM image of a platelet adhering onto a grooved 
patterned a-C:H:F-coated PC substrate: (a) a platelet on a hill of the grooved pattern, 
(b) a platelet bridging between two hills.  
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6.4. Discussion 
6.4.1. Preparation of Sections for TEM observation 
   In this study, we present cross-sectional images of single platelets adhering onto flat 
and groove-patterned a-C:H:F surfaces. TEM analysis presents numerous technical 
difficulties in the preparation of ultrathin sectional samples, and especially in the 
sectioning of a single platelet adhering onto coating materials such as a-C:H family films. 
Although Yoshimoto et al. previously prepared ultrathin sections of platelets and a a-C:H 
coating interface and observed the samples with TEM, their images show cracks and 
fragments of a-C:H films [6.11]. Schakenraad previously suggested that fine-tuning the 
hardness of the biomaterial and embedding medium is necessary for optimal sectioning 
of cell-polymeric material interfaces prior to TEM observation [6.14]. In this study, we 
tuned the hardness of embedding resin by using Araldite-Epon resin as hard as PC 
substrates (Figure 6.2). This is the first examination of an Araldite-Epon mixture for hard 
coated substrates used to embed cells. Furthermore, we tried to optimize the direction of 
sectioning using an ultra-microtome. Consequently, we obtained clear cross-sectional 
images using a horizontal slicing direction (Figure 6.3(c)). When slicing in vertical and 
oblique direction, waves of a-C:H:F film were observed on cross-sectional images 
(Figure 6.3(a),(b)). It is considered that buckling of a-C:H:F film has occurred by the 
compressive stress applied by vertical and oblique slicing like a fiber in unidirectional 
fiber reinforced composite materials [6.15], owing to the lower hardness of PC and 
Araldite-Epon resin than a-C:H:F. In this study, the epoxy resin containing the embedded 
a-C:H:F film-coated PC substrate could be regarded as one of the composite materials 
which have a three-layer structure. It seems that the kink/ buckling of a-C:H:F occurred 
against the compressive stress applied by slicing the composite material of embedding 
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material, substrates (as matrix), and a-C:H:F coating (as fiber) together.  
 
6.4.2. Observation of Platelets Adhering onto a-C:H:F Surface 
   This method was also useful for preparing ultrathin sections of resin-embedded 
platelets on biomaterials such as chemically film-coated and physically pattern-shaped 
surfaces (Figure 6.5, 6). Paknikar et al. reported the observation of platelet cytoskeletal 
dynamics, using recently introduced silicon-rhodamine probes for actin and tubulin to 
characterize cytoskeletal reorganization in situ and in real time [6.16]. They found two 
distinct time scales, for platelet spreading and cytoskeletal reorganization, suggesting that 
the processes have separate molecular origins. However, several aspects of platelet 
function require clarification. For example, little is known about the mechanical function 
of platelets and the coordination of this function with intracellular structural remodeling. 
In this study, we obtained cross-sectional images of platelet interfaces and their internal 
structures and observed internal structures such as the gap between platelet pseudopodia 
and the material surface (Figure 6.5). The proposed method thus will aid future studies 
on this intriguing platelet system. 
   In addition, we observed platelets on groove-patterned a-C:H:F, attached along a hill 
and bridging between hills (Figure 6.6), indicating that flat platelets and OCS dilation 
are promoted on groove-patterned a-C:H:F surfaces compared with flat substrates. 
Several microfabrication methodologies have recently been investigated for generating 
patterned surfaces on a substrate to control platelet adhesion and better understand the 
functions of platelets. Kita et al. reported platelet adhesion and spreading on micro-
patterned fibrinogen and collagen surfaces, showing that the adhesion process is precisely 
regulated by the spatial information of the environment [6.17]. Their results suggest that 
Chapter 6 
 141 
physical features of the environment may regulate platelet activation and adhesion. In this 
study, we reported platelet bridging onto groove-patterned a-C:H:F shown in Figure 6.6. 
Similar platelet bridging was observed by Ding et al. in their study of platelet adhesion 
to groove-patterned TiO2 surfaces [6.18]. They found that 1 µm of block and groove 
pattern resulted in the majority of adhering platelets adopting a bridging mode and platelet 
activation was promoted than the flat surface. Our grooved pattern has approximately 1.5 
µm width; this width is close to the one of 1 µm of block pattern (approximately 1.4 µm) 
and should promote platelet bridging if the hypothesis of Ding et al. is correct. We also 
observed that platelets onto hills of groove released granules regardless of the activation 
stage (Figure 6.6). In addition, we observed that the pseudopodia develop from a point 
on the platelet bottom and extend toward both the hill and the material grooved valley 
space although this phenomenon could not be observed by SEM observation (Figure 
6.4(b)). This suggests that the apical parts of pseudopodia have more complicated motion 
on physically modified material surfaces. Our findings are currently restricted to cross-
sectional analysis using TEM. Other techniques would provide useful information for 
better understanding the mechanism underlying the interactions between platelets and 
surface topographical features. 
   In future we will conduct an immunostaining TEM study to investigate which apical 
parts of pseudopodia recognize features on material surfaces. Ongoing TEM studies such 
as computer tomography or array tomography may aid our understanding of the non-
thrombogenicity of a-C:H:F films and elucidate the critical mechanism underlying 
biomaterial-related thrombosis.   
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6.5. Conclusion 
   In this study, we reported an improved ultrathin sectioning procedure for preparing 
chemically a-C:H:F film-coated biomaterials for TEM observation. This method 
preserved the platelet/coating/substrate interface and the sections were of excellent 
quality without wrinkles and the platelet/coating/substrate complex adhered together well. 
Further, we visualized the boundary structure of a single human platelet on a-C:H:F films 
and grooved and flat substrates and revealed that a bridging platelet bridged between the 
top of the grooved pattern, with the pseudopodia developing from a point on the platelet 
bottom. 
   Observation of granule movement and the adhesion interface at the ultrastructure 
level is only possible using TEM methods. The proposed improved method may allow 
processing of large specimens to investigate chemical and physical surface modifications.  
  
Chapter 6 
 143 
References for Chapter 6 
 
[6.1] H.S. Tran, M.M. Puc, C.W. Hewitt, D.B. Soll, S.W. Marra, V.A. Simonetti, J.H. 
Cilley, A.J. DelRossi, Diamond-like carbon coating and plasma or glow discharge 
treatment of mechanical heart valves, Journal of Investigative Surgery, 12 (1999) 
133-140. 
[6.2] S.L. Goodman, K.S. Tweden, R.M. Albrecht, Platelet interaction with pyrolytic 
carbon heart-valve leaflets, Journal of Biomedical Materials Research, 32 (1996) 
249-258. 
[6.3] J. Sui, Z. Zhang, W. Cai, Surface characteristics and electrochemical corrosion 
behavior of fluorinated diamond-like carbon (F-DLC) films on the NiTi alloys, 
Nuclear Instruments and Methods in Physics Research Section B: Beam 
Interactions with Materials and Atoms, 267 (2009) 2475-2479. 
[6.4] A. Bendavid, P. Martin, L. Randeniya, M. Amin, R. Rohanizadeh, The properties of 
fluorine-containing diamond-like carbon films prepared by pulsed DC plasma-
activated chemical vapour deposition, Diamond and Related Materials, 19 (2010) 
1466-1471. 
[6.5] M. Jiang, Z. Ning, Influence of deposition pressure on the structure and properties 
of fluorinated diamond-like carbon films prepared by RF reactive magnetron 
sputtering, Surface and Coatings Technology, 200 (2006) 3682-3686. 
[6.6] T. Saito, T. Hasebe, S. Yohena, Y. Matsuoka, A. Kamijo, K. Takahashi, T. Suzuki, 
Antithrombogenicity of fluorinated diamond-like carbon films, Diamond and 
Related Materials, 14 (2005) 1116-1119. 
[6.7] T. Hasebe, S. Yohena, A. Kamijo, Y. Okazaki, A. Hotta, K. Takahashi, T. Suzuki, 
Fluorine doping into diamond-like carbon coatings inhibits protein adsorption and 
Chapter 6 
 144 
platelet activation, Journal of Biomedical Materials Research - Part A, 83 (2007) 
1192-1199. 
[6.8] X. Ye, Y.-l. Shao, M. Zhou, J. Li, L. Cai, Research on micro-structure and hemo-
compatibility of the artificial heart valve surface, Applied Surface Science, 255 
(2009) 6686-6690. 
[6.9] C. Mao, C. Liang, W. Luo, J. Bao, J. Shen, X. Hou, W. Zhao, Preparation of lotus-
leaf-like polystyrene micro-and nanostructure films and its blood compatibility, 
Journal of Materials Chemistry, 19 (2009) 9025-9029. 
[6.10] Y. Ding, Z. Yang, C.W.C. Bi, M. Yang, S.L. Xu, X. Lu, N. Huang, P. Huang, Y. 
Leng, Directing vascular cell selectivity and hemocompatibility on patterned 
platforms featuring variable topographic geometry and size, ACS Applied 
Materials & Interfaces, 6 (2014) 12062-12070. 
[6.11] Y. Yoshimoto, T. Hasebe, K. Takahashi, M. Amari, S. Nagashima, A. Kamijo, A. 
Hotta, K. Takahashi, T. Suzuki, Ultrastructural characterization of surface-induced 
platelet activation on artificial materials by transmission electron microscopy, 
Microscopy Research and Technique, 76 (2013) 342-349. 
[6.12] H.H. Mollenhauer, Plastic embedding mixtures for use in electron microscopy, 
Stain technology, 39 (1964) 111-114. 
[6.13] C.W. Geiselman, C.N. Burke, Exact anhydride: Epoxy percentages for Araldite 
and Araldite—Epon embedding, Journal of Ultrastructure Research, 43 (1973) 220-
227. 
[6.14] J. Schakenraad, J. Oosterbaan, E. Blaauw, Preservation of the cell-biomaterial 
interface at the ultrastructural level, Cells and Materials, 1 (1991) 35-40. 
[6.15] B.W. Rosen, Mechanics of composite strengthening, Fibre composite materials, 
American Society of Metals Seminar, Metals Park, OH, 1965. 
Chapter 6 
 145 
[6.16] A.K. Paknikar, B. Eltzner, S. Köster, Direct characterization of cytoskeletal 
reorganization during blood platelet spreading, Progress in Biophysics and 
Molecular Biology, DOI https://doi.org/10.1016/j.pbiomolbio.2018.05.001(2018). 
[6.17] A. Kita, Y. Sakurai, D.R. Myers, R. Rounsevell, J.N. Huang, T.J. Seok, K. Yu, M.C. 
Wu, D.A. Fletcher, W.A. Lam, Microenvironmental geometry guides platelet 
adhesion and spreading: a quantitative analysis at the single cell level, PloS one, 6 
(2011) e26437. 
[6.18] Y. Ding, Y. Leng, N. Huang, P. Yang, X. Lu, X. Ge, F. Ren, K. Wang, L. Lei, X. 
Guo, Effects of microtopographic patterns on platelet adhesion and activation on 
titanium oxide surfaces, Journal of Biomedical Materials Research Part A, 101A 
(2012) 622-632. 
 
 
 
 
 
Chapter 7 
 146 
Chapter 7 
Summary 
 
Major problems with currently available vascular implanted prostheses are a lack of 
anti-thrombogenicity. Fluorine-incorporated hydrogenated amorphous carbon (a-C:H:F) 
films had been considered as an effective coating for imparting biocompatibility to 
medical implant devices and recently has attracted much attention as anti-thrombotic 
coatings for cardiovascular implants. The research in this dissertation has focused on a 
potential for a-C:H:F coatings. I also focused on the development of composite materials 
based on unique properties of a-C:H:F coatings. Furthermore, I researched improvement 
of a-C:H:F coating by reducing hydrogen content and developed blood compatible hard 
a-C:F coating.  
   In the first part of experiments, I reported stability of a-C:H:F coating as 
antithtombogenic coating. In chapter 2, I evaluated the stability of surface chemistry, 
contact angles of surfaces, antithrombogenic properties and adhesive properties on 
metallic stents for a-C:H:F coatings after accelerated aging tests, and determined the 
acceptable stability of a-C:H:F three-layered film as antithrombogenic coatings for 
medical applications. In the next part, I reported improvement of adhesive properties 
between polymer materials and a-C coatings. I proposed the application of a-C:H:F 
coatings on polyurethane (PU) substrates as an anti-sticking layer. Adhesive properties 
between PU and a-C:H:F were improved by Ar plasma treatment, and excellent 
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antithrombogenicity and poor adhesive properties to medical adhesive (n-butyl-2-
cyanoacrylate) of a-C:H:F-coated PU were shown. In chapter 4, a-C:H:F films were used 
as an interlayer of polytetrafluoroethylene (PTFE) and hydrogen-free amorphous carbon 
which has anti-bacterial properties. The surface of PTFE was improved in terms of 
adhesive properties via Ar plasma treatment and the introduction of the interlayer of a-
C:H:F. These results indicated that the pretreated PTFE coated with H-free a-C is a 
promising candidate biomaterial for medical devices. In chapter 5, I proposed a new 
deposition method for fluorine-incorporated a-C which has blood compatibilities and 
hardness to be consistent. Fluorine-incorporated hydrogen-free amorphous carbon (a-
C:F) films were newly synthesized with vacuum arc deposition method focused on both 
blood compatibility of a-C:H:F and excellent mechanical properties of hydrogen-free 
tetrahedral amorphous carbon (ta-C). In this study, I evaluated the influence of fluorine 
doping on ta-C structure and blood compatible properties and hardness of a-C:F films. 
Finally, in chapter 6, I worked on cross-sectional observation of a-C:H:F interface.  
   This thesis stated above indicates beneficial of a-C:H:F films as coatings for medical 
devices and materials. Furthermore, as shown in chapter 5, the new deposition method of 
blood compatible fluorine-incorporated a-C could develop further new composite 
material and result in new applications. The results of this thesis must be useful in the 
implant medicine and medical engineering fields. 
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